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Tick-borne flavivirus (TBF) infections cause morbidity and mortality 
worldwide. A primary goal of vector-borne disease research is to identify ways to 
prevent pathogen and parasite transmission. The black-legged tick, Ixodes 
scapularis, is the only tick species with a sequenced and annotated genome and 
is a vector of TBFs. This project utilizes Langat virus (LGTV) to model TBF infection 
in I. scapularis ISE6 cells. The aims were to (1) characterize the LGTV-ISE6 
system, (2) discover differentially-expressed proteins associated with LGTV 
infection, and (3) identify key genes of interest that were involved in LGTV infection. 
Two proteomic analyses by LC-MS/MS identified 486 and 579 ISE6 proteins (total 
of 764 ISE6 proteins combined). First and second proteomic analyses identified 
68 and 246 ISE6 proteins with increased expression and 198 and 188 ISE6 
proteins with decreased expression, respectively. Greater than 265 ISE6 proteins 
were mapped to cellular function/pathways using Kyoto Encyclopedia of Genes 
and Genomes (KEGG). Greater than 221 ISE6 proteins were identified with no 
KEGG function/pathway. After filtering based on strength of protein identification, 
cellular function/pathway involvement, and an increased expression following
  xii 
 
LGTV infection, ten proteins were selected. Ten selected proteins/genes of interest 
included eight with known function (Fumar, ERP29, DPCD, CNHydro, MDH2, 
PARP, CUKinase, and ACAT1) and two with unknown function (Hypo195 and 
Hypo576). RNA interference knockdown assays were established in ISE6 cells to 
determine effect on LGTV infection. Inhibition of genes of interest involved in 
cellular amino acid, carbohydrate/lipid, and cofactor/vitamin metabolism as well as 
unknown proteins were shown to affect LGTV genome replication and replication. 
In addition, LGTV replication was reduced by perturbing ISE6 metabolic function 
using trichostatin A and oligomycin A and glutamate metabolic function using 
hexachlorophene and epicatechin gallate small molecules in compound assays. 
This research suggested that carbohydrate and amino acid metabolic enzymes 




CHAPTER 1: INTRODUCTION 
 
1.1 THE IXODIDAE (HARD TICKS) AS VECTORS OF PARASITES AND 
PATHOGENS 
Hard ticks (Phylum Arthropoda, Subphylum Chelicerata, Subclass Acari, 
Superorder Parasitiformes, Order Ixodida, Family Ixodidae) are pests of global 
medical and veterinary importance. These obligate ectoparasites transmit a wide 
variety of viruses, bacteria and protozoa to humans and animals. Examples of tick-
borne disease affecting human health include babesiosis, caused by the parasite 
Babesia microti [1], Lyme disease, caused by the bacterium Borrelia burgdorferi 
[2], Rocky Mountain spotted fever, caused by the bacterium Rickettsia rickettsii [3], 
and granulocytic anaplasmosis, caused by Anaplasma phagocytophilum [4]. In 
addition, domesticated animals can be at risk from borreliosis, babesiosis, spotted 
fever, ehrichiosis caused by Ehrlichia species, and hepatozoonosis caused by 
hepatozoon species [5].  In North America, the tick-borne flavivirus (TBF) 
Powassan virus (POWV) and its genotype Deer Tick virus (DTV) can cause 
meningitis and encephalitis in humans and potentially in domestic animals [6, 7]. 
1.2 IXODES SCAPULARIS; GEOGRAPHIC DISTRIBUTION, LIFE CYCLE, AND 
DISEASE TRANSMISSION 
 In United States (U.S.A.), I. scapularis tick is found east of the Rocky 
Mountains from Canada to Florida, and west to the state of Texas. High 





Ixodes scapularis has a two year life cycle in the wild with four 
developmental stages: egg, larva, nymph, and adult. It is considered a three host 
tick as the larva, nymph, and adult feed to repletion on different hosts before 
molting to the next lifestage [12]. Larvae and nymphs feed primarily in the spring 
and throughout summer on small mammals, reptiles, or birds [13, 14]. Adults feed 
primarily in the fall on larger mammals such as deer, fox, raccoon, etc and mate 
during this time. After feeding, adult females drop from the host and lay thousands 
of eggs that then hatch in the following spring. The nymph and adult stages 
(primarily adult females) are primarily responsible for transmission of Lyme 
disease and other tick-borne diseases.  
 Ixodes scapularis is a competent vector for a number of protozoa, bacteria, 
and viruses that cause disease including Babesia microti, Anaplasma spp bacteria, 
Borrelia spp bacteria, and POWV/DTV in the U.S.A. [15-18]. The acquisition of 
parasite and bacteria can occur with the larvae or nymph blood meal, making the 
subsequent stage infective. POWV/DTV can be acquired by transovarial 
transmission and therefore the larva, nymph, and adult stages may be infected 
and capable of virus transmission.  
1.3 TBFS 
TBFs are a complex of 10-11 kb single-stranded, ribonucleic acid (RNA) 
viruses that cause high human morbidity and mortality [19]. Of the family 
Flaviviridae and genus Flavivirus, TBFs have ten proteins that are translated as a 
polyprotein and cleaved by a combination of host and viral proteases. Three 




proteins. Seven nonstructural proteins consist of the nonstructural protein 1 (NS1), 
nonstructural protein 2A (NS2A), nonstructural protein 2B (NS2B), nonstructural 
protein 3 (NS3), nonstructural protein 4A (NS4A), and nonstructural protein (NS4B).  
Many exotic TBFs are identified on the Centers for Disease Control and 
Prevention “Select Biological Agents and Toxins” list (http://www.selectagents.gov/) 
as they have the potential to become established zoonotic diseases in the U.S.A. 
and they are considered possible bioterrorism agents [20]. TBFs result in 
hemorrhagic fever and encephalitis, and are transmitted to human via bite of 
infected Ixodes species tick [21-23]. 
Tick-borne encephalitis virus (TBEV) is arguably one of the most important 
TBFs, and has been reported in Europe, the Far East, and Siberia. Mansfield et al 
reported a 400% increase in TBEV cases in Europe from 1974 to 2003 [23]. The 
geographic range of TBEVs may be changing as several TBEVs have recently 
been reported from a number of “non-endemic” regions, including Norway in 2004 
[24]. Each year more than 10,000 cases of TBEV are reported globally. TBEV-
associated case fatality rates range from 10-40%. Additionally, survivors of TBEV 
infection have a high incidence of permanent neurological sequelae. The actual 
incidence of TBEV is thought to be much higher as many cases are presumably 
undiagnosed [23, 25]. TBEV is classified as biosafety level 4 (BSL-4), and 
consequently, most research aimed at understanding TBFs have been conducted 
using less pathogenic TBFs other than TBEV. Effective prophylactic anti-TBEV 





The POWV is the only TBF documented in the U.S.A. POWV can cause 
encephalitis in humans and domesticated animals, specifically horses, and in rare 
cases, dogs [27]. The virus was first discovered in 1958. POWV is of considerable 
concern because the virus has a high case fatality rate of 10-15% [28] in humans. 
However, confirmed human cases of POWV infection are low in comparison to 
WNV and other mosquito-borne arboviruses. From 2004 to 2013, an average of 
six to seven POWV neuroinvasive diseases cases were reported and fifteen 
confirmed cases were reported from 2013-2014 (CDC; 
cdc.gov/powassan/statistics; diseasemaps.usgs.gov/). Diagnostic testing is limited 
for POWV in patients with symptoms of encephalitis. The incidence rate of POWV 
infection in the U.S.A. is seriously misjudged [29, 30] and more recognition and 
treatment of this emerging viral infection is necessary. The POWV/DTV has no 
anti-viral vaccine or specific therapy for treatment. In addition, survivors have a 
high rate (approximately 50-55% of confirmed cases of infection) of permanent, 
recurring neurological problems [22]. This situation is similar with DTV, which is 
also prevalent in mammal reservoirs and transmitted by I. scapularis [31]. Both 
POWV and DTV are classified as BSL-3, limiting research on these viruses to a 
small number of approved facilities.  
Langat (LGTV) virus is classified as BSL-2 and is widely used as a model 
for TBF research. LGTV is vectored by Ixodes grandulatus and Haemaphysalis 
spp. ticks and the natural mammal reservoir is forest rats (Fig 1; [20]). It can cause 
encephalitis in humans and animals (although LGTV has a low virulence in human 




[32]. Human disease cases of LGTV infection have not been reported but LGTV-
antibodies have been detected in blood samples collected off individuals living in 
endemic regions [20, 23]. In the 1970s, LGTV was used successfully as a live 
vaccine for TBEV, but its use was terminated when it was discovered that the 
vaccine caused encephalitis in approximately 1:10,000 vaccinated individuals [21].  
1.4 PATHOGENESIS OF TBFS IN THE MAMMALIAN HOST AND TICK 
VECTOR 
1.4.1 TBF life cycle 
The flavivirus life cycle begins when the virus binds to the cell surface where 
receptor-mediated endocytosis occurs with the virus entering the cell in an 
endocytic vacuole [33]. Fusion of the viral membrane with the endosomal 
membrane results in the uncoating of the viral nucleocapsid, which releases viral 
RNA into the cell cytoplasm. Protein translation occurs forming a single polyprotein 
formed in the cytoplasm and is intertwined within endoplasmic reticulum (ER) 
membrane. Viral genome replication occurs on the ER membrane [34] in 
replication complexes. Virus assembly and the viral envelope formation occurs 
within the ER and appears as “budding” under electron microscopy imaging. The 
immature (noninfectious) viruses bud into the ER and move through the trans-
Golgi network (TGN), where eventually they are cleaved by a host protease [35]. 
This cleavage creates mature (infectious) viruses, which then exit the host cell 
through exocytosis. 
It has been found that TBF maturation differs between mammalian and tick 
cells. A key difference is that TBEV particles have been detected in the Golgi 




detected in the lumen of vacuoles [36] in tick cells. Yoshii et al has shown that 
TBEV envelope (E) glycosylation, a modification required in the secretory process 
of virions in mammalian cells, does not affect infectious TBEV release from tick 
cells [37]. In addition, inhibiting transport to the Golgi apparatus from the ER 
affected TBEV release in mammalian cells, but not in tick cells. The model for the 
TBF life cycle in mammalian and tick cells is shown in Fig 2.  
1.4.2 Mammalian host 
TBFs first invade epithelial cells at the site of introduction from the bite of 
an infected tick. Eventually, the virus drains into the lymph nodes and systemic 
infection ensues [25]. TBFs are neurotropic where neurons are the primary cell 
type infected [38]. Infection of the brain, spinal cord, and meninges results in 
encephalitic and meningitis symptoms.  
1.4.3 Tick vector 
 Once a tick stage takes a blood meal that contains infectious TBF, infection 
of the midgut tissue occurs and subsequently, invasion of the hemolymph and 
salivary glands. Mitzel et al identified that LGTV titer is an additional factor that 
determines infection within the I. scapularis larva [39]. No reduction in survival of 
I. scapularis larvae occurs with LGTV infection, which suggests that TBF infection 
is not detrimental to tick life stages. LGTV initially infects midgut tissue 
approximately three days post LGTV exposure and secondary organs (including 
salivary glands) at approximately ten days post LGTV exposure. Transstadial and 
transovarial transmission of LGTV and POWV can occur within I. scapularis where 




1.5 IXODES SCAPULARIS GENOMIC RESOURCES 
The only sequenced and assembled tick genome is that of the black-legged 
tick, I. scapularis, available from Genbank, that currently contains 20,486 gene 
models predicted via a combination of ab initio methods and manual curation [42, 
43].  This assembly has been an important resource used to understand both tick 
biology and tick-borne pathogenesis at the molecular level. Mining this genome 
assembly has also allowed for identification of new targets for tick control.  
1.6 TICK CELL LINES AND I. SCAPULARIS ISE6 CELLS 
 Development of tick cell lines are a valuable tool for studies of tick-borne 
pathogenesis [44, 45]. Tick cells have been used extensively to explore tick-borne 
bacterial pathogenesis [46-50]. Tick cell lines have also been utilized as models to 
explore responses to tick-borne viruses [51, 52]. The I. scapularis ISE6 cell line 
and the model TBF LGTV was used to form an in vitro TBF pathogenesis model 
here. One disadvantage of using tick cell lines is possible contamination with 
endogenous tick-borne bacteria or viruses. The I. scapularis IDE8 cell line is known 
to have an endogenous orbivirus, St. Croix River virus [53] and virus-like particles 
have been observed in other tick cell lines as well [54]. Coinfection in tick cell lines 
with some pathogens has shown variable effects on pathogen replication [55]. 
Overall, this emphasizes that proper experimental controls need to be developed 
before conducting TBF research with tick cells.  
1.7 IDENTIFICATION OF HOST CELL FACTORS INVOLVED IN TBF 
INFECTION 
Research has shown that proteins and metabolites produced by human [56, 




in flaviviral infection [62-65]. The mechanisms by which these molecules contribute 
to the replication of flaviviruses are not well understood. Human host cell factors 
have been identifed with Hepatitis C virus (HCV), Dengue virus (DENV), and West 
Nile virus (WNV); however, little is known regarding factors involved in flaviviral 
infection in the vector. Studies conducted in Drosophila and a number of mosquito 
species [58, 62, 66] have identified host factors. However, there has been little 
attention directed towards understanding host factors in the tick system. Studies 
dealing with whole tick and tick cells infected with the tick-borne pathogens 
Anaplasma spp. and Rickettsia montanensis have shown differentially-regulated 
genes and differentially-expressed proteins in response to infection [50, 67-71]. 
These studies give insight into genes and proteins that are upregulated/increased 
expression or downregulated/decreased expression from a pathogen infection, 
respectively. 
 Little work has been done to identify factors produced by the arthropod or 
mammalian host in response to TBF infection. Many studies have focused on 
factors produced by mosquitoes in response to flaviviruses. However, there is 
significant variation between the genomes and host specificities of TBFs and 
mosquito-borne flaviviruses. Studies have also investigated global changes in the 
transcriptome in I. scapularis and in tick cells following LGTV infection [72], 
although there is little known about how these responses correlate to changes at 
the protein level. Tick proteins that facilitate viral infection and replication in the 
arthropod vector are logical targets for interventions aimed at disrupting 




1.8 PROTEOMIC ANALYSES OF HARD TICKS 
A useful tool includes proteomics, used to understand protein expression 
and has the utility for improving genome annotations. High throughput proteomic 
analyses have identified cellular pathways/functions associated with basic tick 
physiology, such as host attachment and blood feeding [73]. Recently, proteomic 
analyses of the I. scapularis ISE6 and IDE12 cell lines, and synganglia have 
identified neuronal proteins suggesting ISE6 cells may be a potential in vitro model 
of the tick synganglia/neurons. Proteomics has also been used to investigate 
interactions between ticks (including tick cells) and bacterial pathogens [70, 71, 74, 
75]. Currently, there is limited understanding of how tick protein expression 
changes following TBF infection.  
1.9 THE NEED FOR DEVELOPMENT OF NEW STRATEGIES AGAINST TBFS 
One of the biggest challenges in vector biology and the long-term goal of 
this research is to identify new ways to prevent transmission of TBFs. There are 
currently no anti-tick vaccines or anti-viral drugs against TBFs [76, 77] and there 
is limited research to understand the infection process of TBFs in the tick vector. 
This gap in our knowledge base is an impediment to the development of new 
strategies against TBFs.  
Historically, developing arthropod control approaches have focused on 
neuronal proteins, enzymes, and receptors. More recently, attention has shifted to 
novel pest control approaches such as those employing RNAi transcript 





pipeline-posts-improved-fiscal-first-q]. RNAi transcript knockdown to identify 
genes of interest in ticks implicated in bacterial pathogenesis has been undertaken 
[78, 79]. Genome assemblies are an important source of sequence information but 
a significant proportion of the gene and conceptual protein repertoire produced by 
automated annotation of arthropod genomes are considered “orphan” sequences, 
or proteins of no known function. These orphan proteins are a potential source of 
novel targets for traditional chemical pesticide development and RNAi-based pest 
control as they may potentially be unique to the arthropod vector. The impact of 
experimentally-identified, tick proteins will allow for identification of potential 
control targets against TBF infection and the tick itself. 
An approach to translate the research herein may rely on the use of proteins 
from this study as antigens to screen to identify small, inhibitory compounds. It was 
hypothesized that the inhibition/knockdown of tick proteins/genes of interest 
involved in TBF infection will reduce virus infection and production of progeny virus 
spread. Upon the identification of involved tick proteins in viral infection, the goal 
is to use specific therapeutic products (antigen development, small molecules, 
proteins/peptides, RNAi-based molecules, etc) to disrupt TBF transmission. It is 
feasible to first identify a select few proteins/genes of interest involved in TBF 
infection within a tick cell line and then to confirm these proteins are involved in 
TBF infection with in vivo studies using whole ticks (Fig 3). 
1.10 OVERVIEW OF THESIS RESEARCH 
The goal of this project was to discover I. scapularis proteins involved in 




analysis of the LGTV-ISE6 cell line model using proteomics to identify tick protein 
expression levels following LGTV infection. The rationale was that some of these 
proteins were involved in viral infection in the cell and whole tick and were thus 
logical targets for strategies to disrupt virus transmission. Overall, it was 
hypothesized that ISE6 cell proteins with increased expression following LGTV 
infection were involved in LGTV infection. The aims were (1) to establish a 
proteomic screen to identify tick proteins associated with TBF infection, (2) to 
characterize tick cellular pathways and functions of tick proteins with altered 
expression following TBF infection, and (3) to determine key tick proteins involved 
in TBF infection.  
This multidisciplinary, collaborative project was the first to investigate how 
flaviviruses perturb the tick proteome. This work was expected to have a broad 
scientific impact as it will provide an essential basis to understand the molecular 
processes that operate in tick cells during infection by TBFs. The findings may lead 
to better medicine to control flavivirus infections, better tick control strategies, 
improved public health, and countermeasures to protect against bioterrorism. In 
addition, it was an integral component of an ongoing international effort to 
understand TBF pathogenesis and analyze the I. scapularis genome. 
 Chapter 2 introduces the establishment of the LGTV-ISE6 cell model 
system. This chapter describes the ISE6 cell growth, LGTV growth within ISE6 
cells, creation of a noninfectious LGTV control, effect on cell population numbers 
following LGTV infection, effect on cell viability following LGTV infection, and effect 




proteomic analyses, a differential and quantitative analysis, to identify hundreds of 
ISE6 proteins with changing expression following LGTV infection associated with 
cellular pathways. Comparative proteomic analysis to other flavivirus-host systems 
were presented as well as cellular pathway changes at different time points 
following LGTV infection, and lysine acetylation of ISE6 proteins associated with 
LGTV infection. Chapter 4 describes small molecule compound and RNA 
interference assays to inhibit a subset of ISE6 proteins (discovered from Chapter 
3) with increased expression following LGTV infection and identify tick molecular 


















1.11 FIGURES, TABLES, AND LEGENDS 
 
Fig 1. Natural transmission cycle of LGTV. LGTV is a zoonotic pathogen and is 
naturally transmitted by Ixodes and Haemaphysalis hard tick species to forest rats. 










Fig 2. LGTV life cycle within the cell. Stages of the LGTV life cycle predicted in 
the mammalian and tick cell. Red box denotes a different LGTV egress route 
suggested in the cell tick, but not in the mammalian cell. Black circles denote 
cellular ribosomes. Blue lines denote positive strand, LGTV RNA genomes. 
Orange lines denote negative strand, LGTV RNA genomes used as a template for 
further positive strand, LGTV RNA genome production. Red circles denote viral 
proteins in association with replication complexes on/in the ER. Purple 
particles/virions denote immature LGTV before prM-furin cleavage. Green circles 






Fig 3. Schematic showing key steps proposed in the translational research 
pipeline to identify tick proteins to use for development of therapeutics and 
anti-tick vaccines. Proposed pipeline to identify ISE6 proteins involved with LGTV 
infection from the present study. Selected proteins can be pursued via functional 
studies and investigated for potential development of antigens or therapeutics 
against TBF infection. Selected proteins need to be characterized with in vivo 













CHAPTER 2: CHARACTERIZATION OF ACUTE LGTV INFECTION IN I. 
SCAPULARIS ISE6 CELLS 
 
2.1 INTRODUCTION  
 Tick cell lines have become appropriate models for tick-borne pathogen 
research [46, 51, 52, 80], especially to identify molecular components involved in 
pathogen infection. LGTV infections have been carried out in ISE6 cells before to 
characterize virus replication [81-83], hence ISE6 cells make an effective model 
for proteomic-based analyses studying tick protein responses with TBF infection. 
 Identifying tick protein changes following TBF infection in ISE6 cells first 
requires characterization of the ISE6-LGTV system (Fig 1). For this study, 
characterization involves (1) identifying ISE6 cell growth, (2) LGTV growth within 
ISE6 cells, (3) effect on cell population numbers following LGTV infection, (4) effect 
on cell viability following post LGTV infection, and effect on cell mortality following 
LGTV infection. It was hypothesized that ISE6 cell viability would not change with 
LGTV infection in comparison with mock (uninfected) treatment. Characterizing the 








2.2 MATERIALS AND METHODS 
2.2.1 Cell and virus culture
Ixodes scapularis embryonic ISE6 cells (provided by T. Kurtti, University of 
Minnesota, Minneapolis, MN) were cultured at 34°C in L15B-300 media in the 
absence of CO2 [44, 45]. Baby hamster kidney 15 (BHK15) cells, used for plaque 
assay and immunofluorescent focus assay (IFA), were cultured with at 37°C in 
Minimum Essential Media (MEM) supplemented with L-glutamine, non-essential 
amino acids (NEAA), and 10% heat-inactivated fetal calf serum (FCS) with 5% 
CO2. Green African monkey kidney Vero cells, used to create LGTV stock and for 
IFA to determine LGTV stock titer, were cultured at 37°C in MEM supplemented 
with L-glutamine, NEAA and 10% heat-inactivated FCS with 5% CO2. LGTV TP21 
wildtype strain, passage 2 (obtained from A. Pletnev, NIH-NAID, Bethesda, MD 
[84]) stock was amplified in Vero cells (multiplicity of infection  0.01) [85] and grown 
as described above, except with 2.5% heat-inactivated FCS, up to passage 4 (p4) 
to provide a working stock for experimental infections. Serial IFAs were conducted 
in parallel as previously described [86] in 96-well cell culture plates to determine 
LGTV stock titers. 
2.2.2 Measurement of ISE6 cell concentrations 
 The concentration of cells in each sample (cells/ml) was estimated by 
counting cell number on a Scepter 2.0 Automated Cell Counter with 40 µM Scepter 
sensors (EMD Millipore; PHCC20040) in order to equalize cell numbers between 
biological replicates and between treatment groups prior to protein extraction. For 




a hemocytometer and subsequently verified by sample analysis on the Scepter 2.0 
Automated Cell Counter. 
2.2.3 LGTV infection in ISE6 cells and measurement of infectious LGTV 
 As described in Grabowski et al [87], serial plaque assays were performed 
using BHK cells to assess LGTV growth and replication via plaque development.  
Media collected from culture of LGTV-infected mammalian or tick cells was serially 
diluted ten-fold in PBS++ (calcium and magnesium) and adsorbed for one hour onto 
~80% confluent BHK cells in 6 well cell culture plates. An agarose overlay infused 
with a 2X MEM, 5% FCS and 2% agarose was added following adsorption. 
Following solidification of agarose, MEM and 2.5% calf serum was added, and 
plates were incubated at 37°C in 5% CO2. Plaque formation was assessed 4-5 
days-post infection (dpi) and cells were stained with ~4% Neutral Red solution 
(Sigma-Aldrich; T6567). 
 Serial immunofluorescent focus assays were conducted in parallel as 
previously described [86, 88] in 96 well cell culture plates to determine LGTV stock 
titers. Ten-fold serial dilutions of media collected from culture of LGTV-infected 
cells was adsorbed (50 uL total volume) onto BHK cells for one hour at 37°C in 5% 
CO2. An infusion of 1.5% carboxymethylcellulose sodium (CMC) solution 
supplemented with 3% MEM with 2.5% fetal calf serum media was added to each 
well and plates were incubated for 36 hours post infection at 37°C in 5% CO2. The 
CMC and media overlay were removed and cells were rinsed five times with 1X 
PBS. Cells were fixed using 4% paraformaldehyde for 15 minutes at room 




at room temperature to permeabilize cells. Following removal of Triton-X 100, cells 
were rinsed five times and blocked with addition of solution BSA/PBS (10mg/mL 
BSA in PBS). Cells were labelled with primary and secondary antibodies and 
immunofluorescent foci were identified at 20x magnification as described above. 
IFAs were used to assess the level of LGTV infection in ISE6 cells. 
Detection of the LGTV non-structural protein 3 (NS3) was performed using YP-
conjugated chicken anti-LGTV NS3 (provided by S. Best, NIH-NAID, Hamilton, MT) 
as primary antibody and IgG-conjugated goat anti-chicken, Alexa Fluor 488 
(Invitrogen, Grand Island, NY; A11039) as secondary antibody. Cell nuclei were 
labeled with 4',6-diamidino-2-phenylindole (DAPI; Life Technologies, Grand Island, 
NY; D1306). Glass coverslips were used to culture and infect cells for the IFAs and 
were placed onto microscope slides, which were viewed on an Olympus model 
IX81F-3 microscope and images were collected using an Olympus U-CMAD3 
camera. Fluorescence excitation was provided by the EXFO X-Cite Series 120PC 
and Olympus IX2-UCB. Image overlays were produced with Metamorph Basic 
v7.6.5.0 software. 
 To establish an MOI and time-point corresponding to optimal LGTV 
replication in ISE6 cells, three concentrations (MOIs of 7, 13, and 26) of LGTV 
were used to infect cells. For each, cells were fixed at 3, 9, 24, and 48 hpi with five 
technical replicates that were imaged under 20x magnification. On the basis of 
complete infection (>96%) in ISE6 cells between two MOIs (7 and 13) and time 
points (24 and 48), an MOI of 10 was selected for subsequent experiments for 




Separately, an assessment of the cumulative virus release was carried out 
in LGTV-infected ISE6 cells at an MOI of 10. Media from these LGTV-infected ISE6 
cells was harvested at 12 hour intervals for up to 120 hours, and subjected to 
plaque assays to measure replication. In addition, LGTV one step growth was 
analyzed in ISE6 cells, where all media were removed and replaced with fresh 
complete media at each time point. Media removed were then subjected to plaque 
assays to measure replication at each time point. 
2.2.4 Production of non-infectious LGTV 
 To create non-infectious LGTV (UV-LGTV), LGTV p4 stock media (~4 x 106 
pfu/mL) was placed in 48 well cell culture plates and treated with UV radiation at a 
distance of 11 cm from a standard (12.4 watt) UV lamp in a biological safety cabinet 
(Nuaire Labgard ES, Plymouth, MN) for 30 second intervals over a five minute 
period. LGTV inactivation was confirmed by blind passage of UV-LGTV on ~2 x 
107 ISE6 cells and ~80% confluent BHK cells, followed by immunofluorescent and 
plaque assay as described by Perera et al. [89] to demonstrate lack of infectivity. 
2.2.5 Cell viability and mortality assays 
 To assess cell viability, cells were treated with alamarBlue reagent (AbD 
Serotec; BUF012A) diluted 1:10 with fresh media for 12 and 2 hours for ISE6 and 
Vero cells, respectively. Fluorescence (excitation at 560nm, emission at 590 nm) 
was measured using a Molecular Devices SpectraMax M5 plate reader coupled 
with SoftMax Pro v4.8 software. Five technical replicates were performed for each 




 A trypan blue cell exclusion assay was used to assess mortality in ISE6 
cells following LGTV infection. Poly-L-Lysine-treated 96-well plates were seeded 
with ISE6 cells for 48 hours to a cell density of ~9 x 104 cells/well. Cells were 
treated with LGTV infection (MOI 10; p4 LGTV stock) or condition media as 
described above. Cells were harvested at 12, 24, 36, and 48 hpi, centrifuged at 
1,510 x g for 5 min, media was removed and the cell pellet was re-suspended in 
1X PBS. Subsequently, a 1:1 0.4% trypan blue:cell suspension, was prepared, 
incubated for ~3 min at RT, the cells were immediately counted using a 
hemocytometer [90] and the percentage of stained ISE6 cells was determined for 
LGTV and mock treatments. Three technical replicates were collected per 
treatment with two biological replicates (n=2). 
2.2.6 Statistical analyses 
 Graphpad Prism (v4.03) was used to perform two-tailed t-test analyses. 
Standard error was completed to show error between technical replicates. At least 
two biological replicate experiments were completed for each experiment. 
2.3 RESULTS 
2.3.1 ISE6 cell growth and characterization of LGTV growth in ISE6 cells 
Ixodes scapularis ISE6 cell growth was first established before 
characterization of LGTV infection in ISE6 cells was carried out. ISE6 cell doubling 
time was determined to be between 4 to 5 days (Fig 2). Timothy J. Kurtti (University 
of Minnesota) confirmed that the Ixodes species-derived cell lines had a 4-7 day 




were slow when compared to most mammalian cell cells and ISE6 cells do not 
form monolayers but grow on top of each other. 
IFAs were used in time course experiments to assess levels of LGTV in 
ISE6 cells (Fig 3). Under the assay conditions described herein, IFA revealed that 
the maximum level of LGTV infection in the ISE6 cell population (>96%) 
corresponded to an MOI of 10 as determined by percentage of cells positive with 
the LGTV NS3 protein (Figs 3A and 3B), and plaque assays revealed that the peak 
of LGTV release from ISE6 cells occurred at 36 hpi (Fig 4). These conditions were 
selected for subsequent proteomic analyses. In addition, an LGTV one step growth 
curve in ISE6 cells with an MOI of 10 identified initial LGTV release at around 12 
hpi and a peak LGTV release at 48 hpi (Fig 5). This suggested that the first round 
of LGTV replication (without reinfection in cells) was ≤12 hpi and that the 36-48 hpi 
range was the period with maximum infectious LGTV release.  
2.3.2 UV inactivated, noninfectious control LGTV 
Plaque assays revealed that UV radiation for 30-60 seconds leads to 50% 
inactivation and ≥120 sec was sufficient to achieve 100% inactivation of LGTV as 
determined by the lack of plaque formation (Fig 6). The minimum time observed 
for lack of LGTV NS3 protein appearance was 3.5 minutes (data not shown). UV-
LGTV used for proteomic analyses and subsequent assays was inactivated for five 
minutes.  
2.3.3 ISE6 cell population numbers, viability, and mortality following LGTV infection 
ISE6 cell population numbers did not change in comparison between LGTV 




the initial infection with LGTV (i.e., ≤48 hpi) but does not change after 48 hpi (48-
60 hpi), as measured based on presence of cellular reducing agents (Fig 8). ISE6 
cell mortality, as measured by counting cells treated with trypan blue after LGTV 
infection or mock treatment, revealed no change with LGTV infection groups (Fig 
9).  
2.4 DISCUSSION 
LGTV can establish persistent infection in ISE6 cells after initial, or acute, 
infection. After peak infectious LGTV release from ISE6 cells, in combination with 
published studies [83], LGTV replication remains primarily linear. This also 
provides phenotypic data that suggested ISE6 cells undergo molecular changes in 
cellular pathways that LGTV may utilize. However, the hypothesis that ISE6 cell 
viability does not change with LGTV infection in comparison with mock treatment 
is rejected since ISE6 cell viability was reduced at ≤48 hpi with LGTV. 
2.4.1 Conditions established for proteomic analyses 
 Characterization of a virus-host system is required before performing any 
type of genomic, transcriptomic, or proteomic analyses. The effect LGTV infection 
has on ISE6 cell population numbers, viability, and mortality can be used to explain 
molecular responses but also can be used to optimize biological sample collection 
for subsequent proteomic analyses. For example, completing the one step growth 
analysis of LGTV-infected ISE6 cells identifies the initial release of infectious LGTV 
around 12 hpi. In addition, cumulative and one step growth analyses identify the 
peak LGTV release from ISE6 cells between 36 to 48 hpi. In initial acute infection, 




hpi was late. Identification of proteins and corresponding pathways/functions can 

























2.5 FIGURES, TABLES, AND LEGENDS 
 
Fig 1. LGTV-ISE6 flavivirus-tick cell system. ISE6 cells are derived from I. 
scapularis embryonic eggs. Wildtype TP21 strain LGTV was utilized in this study 















Fig 2. Ixodes scapularis ISE6 cell population growth. Confluent ISE6 cells are 
~5 x 107 cells. ISE6 cells were split and plated in 48 well plates. Cells were 
consistently flushed off 96 cell surfaces via pipette action and placed on a glass 
hemocytometer for cell counting under a microscope. Standard error shown in 










Fig 3. Quantification of LGTV infection in I. scapularis ISE6 cells via 
immunofluorescence. (A) Immunofluorescent detection of virus in ISE6 cells at 
3, 9, 24 and 48 hours post infection (hpi) with LGTV MOIs of 7, 13 and 26. LGTV 
NS3 nonstructural protein (green), DAPI-stained nuclei (blue). (B) Percentage of 
infected ISE6 cells at 3, 9, 24 and 48 hpi following treatment with LGTV at MOIs 
of 7, 13 and 26 as determined from quantifying ISE6 cells with immunofluorescent 





Fig 4. LGTV cumulative growth in ISE6 cells. Time course experiment showing 
amount of infectious LGTV (Log pfu/mL) released from ISE6 cells initially infected 
with LGTV MOI = 10 (n=3). Small media volume (100 µL) was removed for titration 
and replaced with the same volume of fresh media at each time point. Titration 
was performed using both plaque assays and immunofluorescent focus forming 
assays in BHK cells. Standard error shown in error bars with three technical 









Fig 5. LGTV one step growth in ISE6 cells. Time course experiment showing 
amount of infectious LGTV (pfu/mL) released from ISE6 cells initially infected with 
LGTV MOI = 10. All media was removed for titration and replaced with fresh media 
at each time point. Titration was performed using plaque assays in BHK cells. 
Standard error shown in error bars using three technical replicates. Two biological 










Fig 6. UV-activation of LGTV to create noninfectious LGTV (UV-LGTV). Plaque 
assays in BHK cells showing the reduction in infectious viral titer (pfu/mL) following 
treatment with UV-irradiated LGTV viral stocks for up to 300 seconds. Three 















Fig 7. ISE6 cell growth following LGTV infection. LGTV infection (MOI 10) and 
mock treatment of ISE6 cells were completed on ISE6 cells in a 96 well plate. Cells 
were consistently flushed off 96 cell surfaces via pipette action, diluted 1/10th the 
original volume, and placed on a glass hemocytometer for cell counting under a 
microscope. Standard error shown in error bars with three technical replicates. 








Fig 8. ISE6 cell viability following LGTV infection. Alteration of ISE6 cell viability 
at 12-24, 24-36, 36-48 hours post infection are shown with and without LGTV 
(mock-treated) infection. * denotes p<0.05 and ** denotes p<0.01. RLU denotes 
relative light units (fluorescent measurement with 560 nm excitation and 590 
emission). Standard error of the mean shown in error bars with five technical 











Fig 9. ISE6 cell mortality following LGTV infection. Using the trypan Blue cell 
exclusion assay, cell mortality percentage at 12, 24, 36, 48 hours post infection 
with and without LGTV (mock-treated) infection was completed. Standard error 
shown in error bars with five technical replicates. Two biological replicate 
















CHAPTER 3: LC-MS/MS PROTEOMIC ANALYSES OF LGTV-INFECTED I. 
SCAPULARIS ISE6 CELLS 
 
3.1 INTRODUCTION  
 Based on the results presented in Chapter 2 for optimizing/characterizing 
LGTV infection in ISE6 cells, preparation of biological samples necessary for 
proteomic analyses was carried out as described in this chapter. Identification of 
ISE6 proteins with altered levels following LGTV infection was completed at 36 hpi, 
or peak infectious LGTV release. To compare different biological treatment groups, 
comparative/quantitative (differential) proteomics was an appropriate method to 
identify alteration in tick protein expression levels. Once proteins were identified, 
cellular pathway/function and protein domain analyses were carried out. Key 
metabolic and gene regulation pathways were identified, along with identification 
of tick proteins with or without orthology.  
The proteomic response in earlier time points post LGTV acute infection 
was also explored, where key proteins/pathways may be linked with the initial 
release of LGTV from ISE6 cells. Also, further validation of ISE6 proteins with a 
second proteomic analysis provided an increased confidence of protein 
identification. In addition, a recent proteomic study of I. scapularis tick cells and 
synganglia [91] provided identification of tick neuronal proteins that overlap with 




to change in expression levels following neurovirulent LGTV infection. Third, by 
identifying changing ISE6 proteins following different time points post LGTV 
infection, cellular pathways/functions that were changing/fluctuating can be 
identified. Fourth, PTMs during TBF infection have not been explored and were 
hypothesized to be associated, and potentially involved in TBF infection. 
Specifically, lysine acetylation level change among ISE6 proteins was explored 
following LGTV infection. Label-free quantification (LFQ) proteomic analysis of 
ISE6 cells at 12, 24, 36, and 48 hours post LGTV infection was carried out to 
identify metabolic and gene regulatory proteins, which were further subjected to 
comparative analyses, pathway/functional cluster analyses, and PTM searches. 
 Reduced ISE6 cell viability following LGTV infection was identified in 
Chapter 2, a consequence of reduced cellular energy (a decrease in reducing 
agents suggest reduced ATP levels). TCA cycle and oxidative phosphorylation 
pathways were involved in cellular respiration and production of ATP. It was 
hypothesized that more ISE6 TCA cycle and oxidative phosphorylation proteins 
have decreased expression than increased expression following 12-48 hpi with 
LGTV. The rationale was that reduced protein expression was leading to 
decreased production of cellular reducing agents (NADH, NADPH, etc). The LFQ 
proteomic analysis of ISE6 cells at 12, 24, 36, and 48 hours post LGTV infection 







3.2 MATERIALS AND METHODS 
3.2.1 Cell and virus culture 
 Cells and virus stocks were prepared as described in Chapter 2, Section 
2.2.1. 
3.2.2 LGTV infection in ISE6 cells and measurement of infectious LGTV  
 LGTV infection of ISE6 cells and measurement of infectious LGTV was 
completed as described in Chapter 2, Section 2.2.3. 
3.2.3 Production of non-infectious LGTV 
 Production of non-infectious LGTV was completed as described in Chapter 
2, Section 2.2.4. 
3.2.4 Preparation of peptide samples and mass spectrometry analyses 
3.2.4.1 Preparation of ISE6 cell samples for LC-MS/MS analysis  
 To establish LGTV infection in ISE6 cells for LC-MS/MS analyses, ~2 x 106 
ISE6 cells were adsorbed with LGTV p4 at an MOI of 10 for one hour as previously 
mentioned. Infection of >96% of the cells was confirmed by IFA. In parallel, ISE6 
cells were adsorbed with UV-inactivated LGTV and conditioned media (obtained 
from uninfected Vero cell culture). The production of these three treatment groups 
representing cells treated with (a) infectious LGTV (LGTV), (b) non-infectious 
LGTV (UV-LGTV) and (c) conditioned media only (mock control) was replicated 
five times (n=5 biological replicates). Samples were harvested at 36 hpi and were 
adjusted to ~1.7 x 105 cells to ensure an equal concentration of cells per replicate. 
Cells were then pelleted at 1,510 x g for 5 minutes, culture supernatant was 




proteomic analysis were thawed, re-suspended with hypotonic 100 mM 
ammonium bicarbonate buffer, subjected to passive lysis (30 minutes), and mixed 
manually by pipetting at room temperature (RT). Protein concentration was 
determined using a NanoDrop 2000c (Thermo Scientific) in protein a280 mode 
(v1.2.1). Cell pellets used for the LFQ proteomic analysis were thawed, re-
suspended with hypotonic 100 mM ammonium bicarbonate buffer, and subjected 
to freeze-thaw lysis for three cycles with mixing via pipette action at each thaw. 
Protein concentration was determined using Whatman Protran BA85 
Nitrocellulose (Ref: 10402594) with protein standard concentrations. 
Chloroform:methanol (2:1) extraction was performed and proteins from the 
aqueous phase was collected [92, 93]. Proteins were precipitated by addition of 
ice cold 100% acetone to samples, followed by vortexing for five seconds, and 
incubation at -20°C for one hour. Samples were spun at 16,000 x g for five minutes 
and the protein pellet was re-suspended in 8M urea supplemented with 10mM DTT 
and incubated at 37°C for 1.5 hours. Proteins were denatured by addition of a 
50mM ammonium bicarbonate solution supplemented with acetonitrile (ACN), 
triethylphosphine (TEP), and 2-iodoethanol (97.5%:0.5%:2%) [92, 93]. Protein 
pellets for the differential proteomic analysis were dried on a speed vacuum for 
two hours at 37°C and digested for 18 hours at 37°C in 50 mM trypsin (Sigma-
Aldrich; T6567) solution (diluted in ammonium bicarbonate) at a ratio of 1:50 w/w 
trypsin:protein [93]. Protein pellets for the LFQ quantitative proteomic analysis 
were dried on a speed vacuum for two hours at 37°C, resuspended in 50 mM 




ratio of 1:50 w/w trypsin:protein, subjected to barocycler (Pressure BioSciences 
Inc.; NEP2320) pressure-induced digestion at 50°C for the following conditions: 60 
cycles of 20,000 psi for 50 seconds on high pressure and 10 seconds on low 
pressure, and macrospin C18 columns (The Nest Group, Inc.; SMM SS18V) were 
used. 
3.2.4.2 LC-MS/MS analyses and identification of proteins in ISE6 cell samples 
3.2.4.2.1 Differential proteomic analysis 
 Trypic, molecular species of peptides were separated on a nanoLC system 
(1100 Series LC, Agilent Technologies, Santa Clara, CA). Peptides were loaded 
on an Agilent 300SB-C18 enrichment column for concentration and the column 
was switched into the nano-flow path for five minutes. Peptides were separated 
with a C18 reversed phase ZORBAX 300SB-C18 analytical column (0.75 μm x 150 
mm, 3.5 μm) from Agilent.  
The column was connected to the emission tip from New Objective and 
coupled to the nano-electrospray ionization (ESI) source of the hybrid ion trap 
mass spectrometer LTQ-Orbitrap LX (Thermo Scientific). The peptides were eluted 
from the column using an acetonitrile/0.1% formic acid (FA; mobile phase B) linear 
gradient. The column was equilibrated with 95% H2O/0.1% FA (mobile phase A) 
for 5 min and proteins were eluted using a linear gradient of 5%-35% B for 50 
minutes at 0.3 μL/min, followed by a linear gradient of 35%-100% B for 10 minutes. 
The column was washed with 100% of ACN/0.1% FA and equilibrated with 95% of 




between every five samples (of each treatment group) was completed to avoid 
carryover. 
 Operation was completed in the data-dependent positive acquisition mode 
in which full MS scan (resolution 30,000) was followed by four MS/MS scans. The 
four most abundant molecular ions were selected and fragmented by collision-
induced dissociation (CID) using a normalized collision energy of 35%. Raw data 
was collected via Xcaliber (v 2.0.7). Database searches were conducted using 
Spectrum Mill (MS Proteomics Workbench v.03.02 software; Agilent 
Technologies). To identify peptides, a homology search was conducted against 
the VectorBase I. scapularis IscaW1.2 annotation [94] protein dataset (precursor 
mass tolerance=0.05 Da; fragment mass tolerance=0.6 Da; maximum of two 
tryptic mis-cleavages) using Spectrum Mill [92, 93]. Only those peptides with a 
Spectrum Mill score of ≥ 5 and scored peak intensity (% spi) of ≥ 70% were 
considered [92, 93, 95].  
To account for false positives, a decoy (reversed) database search was 
performed using the MS/MS search option in Spectrum Mill. Peptide scores were 
compared to those of reversed peptide scores to obtain a delta forward-reverse 
score. The cut-off was established as >1 for +1 parent charged peptides and +2 
parent charged peptides and >2 for +3 (and greater) parent charged peptides [95]. 
3.2.4.2.2 LFQ quantitative proteomic analysis 
Peptides were loaded into a C18 trap column (200 µm x 0.5 mm, ChromXP 
C18-CL, 3 µm, 120 Å, Eksigent) and the separation was carried out in a capillary 




nanoHPLC system (Ekspert nanoLC 400, Eksigent). The elution was performed 
with the following gradient: 1 min in 5% solvent B (Solvent A: 0.1% FA and solvent 
B: 100% ACN/ 0.1% FA), 5-35% solvent B in 90 min, 35-80% solvent B in 2 min, 
5 min in 80% solvent B, 80-5% B in 2 min, and hold in 5% for 20 min. The flow rate 
was constant at 200 nL/min over the whole gradient. Eluting peptides were directly 
analyzed in an electrospray ionization mass spectrometer (TripleTOF 5600+, AB 
Sciex). Full-MS spectra were collected in the range of 400 to 1600 m/z and the top 
50 most intense parent ions were submitted to fragmentation for 50 milliseconds 
using rolling-collision energy. 
Identification and quantification of peptides were performed with MaxQuant 
software (v 1.5.2.8). Species-specific sequence database of LGTV strain TP21 and 
I. scapularis were downloaded from Uniprot on 01/20/2015. Database searches 
were performed considering cysteine carbamidomethylation as a fixed 
modification, protein N-terminal acetylation and oxidation of methionine as variable 
modifications. Peptide mass tolerance was set to 0.07 and 0.02 Da for first and 
second database searches, respectively. Identified peptides were filtered with 1% 
false-discovery rate at peptide-spectrum match and protein levels. For extracting 
peak areas, peptides that were not found in all the runs were matched based on 
the precise mass and retention time alignment. Proteins only with two or more 
peptides identified were selected. To account for false positives and protein 
contaminants, a decoy (reversed) database search and UniProt contaminant 





3.2.4.3 LC-MS differential analysis of LGTV-infected ISE6 cell samples 
 The Omics Discovery Pipeline (ODP; omicsdp.org) was employed for 
differential protein analyses with mass spectrometry proteomics [92, 93, 96, 97]. 
Raw data from LC-MS/MS runs were uploaded and total ion chromatograph 
visualization was completed with each sample run and treatment group. 
Deconvolution of spectra into peaks was completed for each sample utilizing 
XMass using the GISTool [98]. Alignment of peaks using XAlign [99] was 
conducted and normalization was accomplished from a number of different 
methods [100-102] that best fit the data. Normalized files were subject to statistical 
analyses and pattern recognition analysis. A heat map was created using the 
Heatmap.2 function of the ‘gplots’ package in R. Normalized files subjected to 
statistical analyses also were subject to principal component analysis (PCA), self-
organizing maps (SOM), and linear discriminate analysis (LDA) (unpublished data). 
For more information regarding the specific components of the ODP, refer to [96].  
3.2.4.4 LFQ quantitative analysis of LGTV-infected ISE6 cell samples 
The average LFQ intensity values for the technical replicates were used for 
each sample and submitted to InfernoRDN ([103]; 
http://omics.pnl.gov/software/infernordn). All the values were transformed [log2(x)] 
and the Liner Regression Normalization and Central Tendancy options were 
applied. The results table files and GO annotation files were loaded into MS 






3.2.4.5 Post-translational modification search of ISE6 proteins 
 MaxQuant software was utilized to search the I. scapularis database with 
lysine acetylation along with the other variable modifications mentioned above. 
Upon search completion, proteins identified with modified peptides and identified 
in at least three out of five samples of at least one treatment group were subjected 
to two sample t-test and ANOVA statistical analyses via GraphPad Prism software 
(v 4.03) to identify statistically-significant changes in modifications following LGTV 
infection and UV-LGTV treatment.  
3.2.5 Measurement of ISE6 cell concentrations 
 Measurement of ISE6 cell concentrations was completed as described in 
Chapter 2, Section 2.2.2. 
3.2.6 Statistical analyses 
 Following alignment and normalization of MS peaks, standard two-sample 
t-test and Wilcoxon-Mann-Whitney rank test (unpublished data) were used to 
compare significant differences between mass profiles of the samples. An ANOVA 
was also utilized to identify significant masses across the three treatment groups 
and identify group differences of the three-sample analysis. Statistics were 
incorporated using the R statistical package (http://www.r-project.org/). Application 
of a false discovery rate based correction method [104] was performed with the 
significance tests. 
 For the differential proteomic analysis, the following methodology was used 
to account for the average fold change of a protein with multiple peptides: (1) Log 




identified an averaged Log-valued protein intensity fold change; (3) the natural Log 
(ln) of the averaged Log-valued protein intensity fold change was determined in 
order to convert values to the original average fold change value for the 
corresponding protein. The “flattening” of the data was a stringent approach to 
identify the differential change in MS peak intensities for a particular protein. Fold 
change of >2 was considered an increase in expression, 0.5-2 fold change denotes 
no change in expression, and fold change of ˂0.5 corresponds to a decrease in 
expression. 
3.2.7 Assignment of ISE6 proteins to function, class, and pathway 
 Peptides with homology to I. scapularis, IscaW1.2 gene models were 
assigned to a putative functional class by searching accession numbers against 
the KEGG orthology database (http://www.genome.jp/kegg/ko.html) and the 
KEGG pathway database (http://www.genome.jp/kegg/pathway.html). ISE6 
proteins with orthology to KEGG entries were populated within KEGG pathways 
that also included mammalian and arthropod orthologs. 
3.2.8 Biological clustering and assignment of ISE6 proteins to function, class, and 
pathway 
 Database for Annotation, Visualization, and Integrated Discovery (DAVID; 
http://david.abcc.ncifcrf.gov/summary.jsp; [105, 106]) was utilized to identify I. 
scapularis proteins with and without orthology (KEGG Orthology). In addition, 
DAVD was utilized to identify significant, biological clustering from Gene 





Peptides with homology to I. scapularis, IscaW1 gene models were 
assigned to putative functional class by searching accession numbers against the 
KEGG orthology database (http://www.genome.jp/kegg/ko.html; [107, 108]) and 
the KEGG pathway database (http://www.genome.jp/kegg/pathway.html). ISE6 
proteins with orthology to KEGG entries were populated within KEGG pathways 
that also included mammalian and arthropod orthologs. 
3.3 RESULTS 
3.3.1 Differential proteomics: Effects of LGTV infection on the ISE6 proteome 
Completion of the virus life cycle as determined by release of infectious 
virus particles was observed in ISE6 cells infected with LGTV. In comparison, in 
cells treated with UV-inactivated virus (UV-LGTV) we observed no release of 
infectious virus particles. Comparative proteomics analyses were used to identify 
proteins expressed throughout the process of cell infection (LGTV) versus those 
associated only with viral attachment and entry of the host cell (UV-LGTV). The 
sequence of proteomic analyses performed using the three treatments (LGTV, UV-
LGTV, and mock) are shown in Fig 1 and Table 1.  
LC-MS data were compared for LGTV, UV-LGTV and mock samples (Fig 
2). The expression patterns of LC-MS peaks for LGTV samples were more similar 
to that of UV-LGTV samples than to that of mock samples. The t-test and ANOVA 
were used to identify proteins that exhibited differential expression (p < 0.05) 
between LGTV and UV-LGTV samples as compared to the mock samples (Fig 3A). 
In total, 486 ISE6 proteins were identified based by homology to NCBI/VectorBase 




expressed in the LGTV and UV-LGTV samples, respectively, compared to mock 
samples. Sixty-eight proteins had increased expression, while 198 proteins 
showed decreased expression in the LGTV samples as compared to mock 
samples. Additionally, 82 and 166 proteins showed increased and decreased 
expression (Fig 3B), respectively, in the UV-LGTV samples in comparison to mock 
samples. Overall, 243 proteins (50%) exhibited decreased expression while 120 
(24.7%) showed increased expression in LGTV and UV-LGTV samples as 
compared to the mock treatment (Fig 4A).  
3.3.2 Differential proteomics: Functional analyses of I. scapularis ISE6 proteins 
Of the 486 ISE6 proteins identified in this study, 265 (54.5%) mapped to 
orthologous proteins in the KEGG database, while 221 proteins had no match 
(KEGG; genome.jp/keg/ko). Of the 265 proteins, 176 (36.2%) mapped to 66 KEGG 
pathways and 16 KEGG modules (Fig 5A). The KEGG pathways identified in the 
present study were categorized into five cellular functions: “metabolism”, “genetic 
information processing”, “environmental information processing”, “cellular 
processes”, and “organismal systems”. The majority of proteins (52%) were 
identified to the functional category “genetic information processing”, followed by 
“metabolic” (38.7%) and “cellular” (6.3%), “environmental information processing” 
(2%), and “organismal systems” (1%) (Fig 5B).  
LGTV samples exhibited the highest number of proteins (53) identified to 
the KEGG pathway “genetic information processing” (Fig 4B-4D). Within this group, 
eight proteins exhibited increased expression and were classified in the pathway, 




were also classified in the pathway, “genetic information processing”. The majority 
of proteins exhibiting increased expression (17) were classified in the protein 
processing pathways of “folding, sorting, and degradation” (7 proteins; 41.2%), 
followed by “translation” (6 proteins; 35.3%) and “transcription” (4 proteins; 23.5%). 
Proteins from the LGTV and UV-LGTV samples that lacked a match to 
KEGG database entries also displayed differential expression. Of these, 30 
proteins had increased expression and 91 had decreased expression in LGTV 
samples in comparison to mock samples (Fig 6). Additionally, 38 and 85 proteins 
were identified with increased and decreased expression, respectively, in the UV-
LGTV samples as compared to mock samples.  
3.3.3 Differential proteomics: Changes in the ISE6 cell proteome following LGTV 
infection 
 Proteins that showed an increase in expression in LGTV samples were 
mapped onto the KEGG functional categories of cell signaling (CYC, STK3, RPS6), 
proteolysis (UCHL3, PSMA, UBE2N), carbon-nitrogen hydrolase activity (DDAH, 
VNN), replication and mRNA processing (PARP, TRA2, CUTL, H2A, CSTF2), 
translation (RPS6, RPL17, AARS, NARS), glutamate metabolism/glutaminolysis 
(prostate-specific transglutaminase ISCW011739; Fig 7 and Table 2), pyruvate 
metabolism and energy association (MDH2; Fig 8). Proteins that exhibited 
decreased expression were associated with the functional categories of glycolysis 
(GAPDH; Fig 8), energy processes (ATP5H, ATP5A1), and mRNA surveillance 






3.3.4 Differential proteomics: Changes in the ISE6 cell proteome following UV-
LGTV treatment 
 Proteins exhibiting increased expression in UV-LGTV samples were 
mapped onto the KEGG functional categories of signaling (RHOGDI, RAB35, SIP, 
LAMC1), cytoskeletal components, (ACTN, TUBA), unfolded protein response and 
ER-associated degradation (HSPA1_8, RAB7A), lysosomal functions (PSAP), and 
phagosome functions (RAB7A). Proteins that exhibited a decrease in expression 
were associated with transport (BAP31), cell survival (BAP31, HYOU1, DERL1, 
GROEL), cell growth (SUMO, NOP10, MAD1L), translation (NOP10), and protein 
folding (GROEL). 
3.3.5 Differential proteomics: Changes in the ISE6 cell proteome common to both 
LGTV infection and UV-LGTV treatment 
 Responses common to LGTV and UV-LGTV samples included proteins 
exhibiting increased expression and associated with signaling (ITGB, MO25), 
cytoskeletal structure perturbation (TLN), amino acid metabolism (ACAT, DP5CD, 
GLUD1, CARP, FAH), glutamate metabolism/glutaminolysis (DP5CD, GLUD1, 
membrane protein (ISCW001521; Fig 7 and Table 2), RNA interference (AUB), 
and energy-production (ACAT). Proteins with decreased expression and common 
to both treatment groups were classified to KEGG functions of glycolysis 
(ALDOA/B/C, ALDH2/1B1/3A2; Fig 8), energy association (ATP5D, ATP5B), RNA 
interference (VIP), and structural manipulation (ACTB_G1, TUBB).  
3.3.6 Differential proteomics: Comparative proteomics of tick, mosquito, and 
human-flaviviral infection 
185 of the 265 ISE6 proteins with orthology to KEGG entries (70%) were 
also identified in a proteomics study of HCV infection of HUH7.5 cells [56] (Fig 9). 




virus (WNV) infection of Vero cells [109], 16 proteins matched orthologs in a yeast 
two-hybrid study of flavivirus-host interactions [110], and 15 proteins (5%) matched 
orthologs identified in Aedes aegypti infected with dengue virus (DENV) [65]. A 
subset of proteins that exhibited increased expression following LGTV infection 
and/or UV-LGTV treatment and matched proteins in the studies above, were 
associated with protein synthesis and proteolysis (Fig 10). Of the remaining 66 
proteins (24.9%), those that exhibited increased expression in LGTV samples were 
classified in the KEGG functional categories of proteolysis (PMSA, CARP), ATP 
association/interaction (PSMA, ANMK), cell and matrix adhesion (VNN, ITGB), and 
as well as oxidative stress and redox homeostasis (VNN and conserved 
hypothetical protein ISCW020127-PA). Additionally, the cellular function of 
hydrolase activity was suggested by increased expression of PSMA and VNN.  
3.3.7 LFQ quantitative proteomics: ISE6 protein and neuronal protein overlap 
The sequence of proteomic analyses performed using the three treatments 
(LGTV, UV-LGTV, and mock) and the four time points (12, 24, 36, and 48 hpi) is 
shown in Fig 11 and Table 3. Identification of 579 proteins (Fig 12) from the LFQ 
proteomic analysis (all ISE6 proteins from 12, 24, 36, and 48 hpi; Fig 13) 
overlapped with 301 proteins from the differential proteomics analysis (486 ISE6 
proteins). A recent study published by Oliver et al [91] identified I. scapularis 
synganglia proteins where 115 of these proteins overlap with the LFQ and/or 
differential proteomic analyses (Fig 14). Changes in expression following LGTV 
infection was initially searched and identified with the overlapped ISE6 and 




3.3.8 LFQ quantitative proteomics: Biological function clustering of ISE6 proteins 
changing with LGTV infection 
Of the ISE6 proteins with statistically-significant changing expressions 
following LGTV infection, DAVID searches revealed greater numbers of biological 
clusters (similar biological function among proteins identified with statistical 
significance) within the 12 and 24 hpi time points than in the 36 and 48 hpi time 
points (Table 4 and Table 5). ISE6 proteins with increased expression identified 
the most clusters. At 12 hpi, the biological cluster of macromolecular complex 
assembly and subunit assembly was unique to this time point. At 24 hpi, the 
biological clusters of protein folding and unfolded protein response, glycosylation 
activitiy and ER involvement, protein synthesis/elongation activity, and 
cofactor/NAD/NADH binding were unique to this time point. At 12 and 24 hpi, the 
biological clusters of ribonucleotide complex/ribosome/translation, heat shock 
protein activity, nucleotide/ribonucleotide binding, thioredoxin 
function/homeostatic response, and GTPase activity were observed. No biological 
clusters were identified at 36 hpi and the biological cluster of RNA 
recognition/nucleotide binding was observed at both 24 and 48 hpi. ISE6 proteins 
with decreased expression identified two biological clusters only at 24 hpi, where 
RNA recognition/nucleotide binding and ATP/nucleotide/ribonucleotide/nitrogen 
biosynthetic/metabolic processes/cation transmembrane transporter activity was 
observed. 
3.3.9 LFQ quantitative proteomics: Cellular pathway fluctuations following LGTV 
infection 
Pathways with proteins with increased expression were seen in greater 




decreased expression were seen in great amount at 48 hpi (Fig 15). Pathways with 
proteins of increased expression (at 12 to 24 hpi) begin to have no to little protein 
change (identified at 36 hpi) and then have decreased expression later (48 hpi) in 
LGTV infection (Fig 16). 
There were 34 pathways with at least two or more proteins identified with 
increased and/or decreased expression following LGTV infection. In addition, there 
were 36 pathways with proteins of increased expression at 12/24 hpi that shifted 
to decreased expression at 36/48 hpi or vice versa. Metabolic pathways were 
primarily perturbed across 12 to 48 hpi (Fig 17). Amino acid and carbohydrate 
metabolic pathways were the top two pathways with proteins of increased 
expression early in infection at 12 and 24 hpi. Two amino acid pathways (histidine 
metabolism and lysine biosynthesis) were identified with proteins of increased 
expression early infection. The third most important metabolic pathways with 
proteins with increased expression at 12 hpi were lipid, cofactors/vitamins, and 
xenobiotics biodegradation metabolism. The third most important metabolic 
pathway with proteins with increased expression at 24 hpi was cofactors/vitamins. 
Carbohydrate metabolism was identified with proteins with increased expression 
only early in infection at 12 and 24 hpi. Pathway shifts occur, first with lipid/fatty 
acid metabolism along with cofactor/vitamin metabolism, which were identified with 
proteins of increased expression early in infection at 12 and 24 hpi, where lipid/fatty 
acid metabolism (three pathways: fatty acid elongation, fatty acid degradation, and 
fatty acid metabolism) was identified late in infection (36 and 48 hpi) with proteins 




citrate/TCA cycle, oxidative phosphorylation, pyruvate metabolism, carbon 
metabolism, and 2-oxocarboxylic acid metabolism) which was identified with 
proteins of increased expression at 12 and/or 24 hpi, where proteins have shifted 
with decreased expression in these pathways at either 24, 36, and/or 48 hpi. Fig 
18 highlights protein expression change in the citrate/TCA cycle following the early 
and late time points post LGTV infection. Glycan biosynthesis was identified with 
proteins with increased expression early in infection at 12 and 24 hpi, but have 
proteins with decreased expression later at 48 hpi. Biosynthesis of amino acids 
was found only at 12 hpi with increased protein expression, where a shift to 
proteins with decreased expression occurred later at 24 and 48 hpi.  
Genetic information processing (GIP; pathways involved with gene 
regulation) pathways account for the second most common cellular function being 
perturbed with LGTV infection across 12 to 48 hpi. Translation pathway was the 
top GIP pathway with proteins of increased expression at 12 and 24 hpi. Only at 
12 hpi, replication/repair pathway was also a shared top pathway with translation 
with proteins of increased expression. Only three GIP pathways were perturbed 
across 12 to 48 hpi: Translation, replication/repair, and folding/sorting/degradation. 
The only GIP pathway identified with proteins of increased expression across 12, 
24, 36, and 48 hpi was the folding/sorting/degradation pathway. Nine GIP 
pathways (ribosome biogenesis in eukaryotes, ribosome, RNA transport, DNA 
replication, spliceosome, proteasome, nucleotide excision repair, protein 




proteins of increased expression at 12 and/or 24 hpi and with proteins with 
decreased expression at 36 and/or 48 hpi or vice versa.  
The only cellular processes pathway being perturbed across 12 to 48 hpi 
was transport and catabolism. A shift was clearly seen with proteins of increased 
expression in this pathway only at 12 and 24 hpi and with proteins of decreased 
expression in the pathway only at 36 and 48 hpi (four pathways: lysosome, 
endocytosis, phagosome, and peroxisome). Endocytosis was the only specific 
transport and catabolism pathway found with proteins with increased expression 
only at 12 and 24 hpi.  
Signaling transduction pathways (FoxO and Wnt signaling pathways) were 
only found with proteins of increased expression early in infection, at 12 hpi. 
Signaling molecules and interaction pathway ECM-receptor interaction was found 
with proteins with decreased expression at 24 and 48 hpi. 
3.3.10 LFQ quantitative proteomics: ISE6 protein lysine acetylation change 
associated with LGTV infection and UV-LGTV treatment 
 Changes in expression of lysine acetylation of ISE6 proteins was shown 
across 12 to 48 hpi with LGTV infection and/or UV-LGTV treatment. Only at 12 
and 24 hpi, Histone H3 (ISCW002300 and ISCW003178) was identified with 
changing expressions of lysine acetylated peptides with LGTV infection and/or UV-
LGTV treatment (Fig 19). However, more Histone H3 peptides with lysine 
acetylation were identified with increased expression following LGTV infection than 
with decreased expression. In addition, at 12 hpi the secreted protein 
(ISCW020023) was identified with increased expression of an acetylated peptide 




following LGTV infection were found with the SMC protein (ISCW015559) and the 
Iron-containing alcohol dehydrogenase (ISCW021748). Additionally, the 
uncharacterized protein (ISCW006009) was found with an acetylated peptide with 
decreased expression following UV-LGTV treatment. Histone H4 was found with 
acetylated peptides with changing expression in all time points of LGTV infection 
(Histone H3 acetylated peptides observed early in infection). Histone H4 
acetylated peptides with increased and decreased expression were found in 12 
and 36 hpi. Histone H4 acetylated peptides with increased expression only was 
found at 48 hpi. Histone H4 acetylated peptides with decreased expression only 
was found at 24 hpi. 
3.4 DISCUSSION 
We used an LC-MS/MS proteomics approach to analyze changes in the 
global protein expression profile of I. scapularis ISE6 cells following infection with 
LGTV and identified tick proteins tied to flavivirus infection and replication. The 
present study focused on proteins expressed during 36 hours post infection or the 
period of peak LGTV release from infected ISE6 cells. In total, 486 ISE6 proteins 
were identified, and of these, 66 exhibited increased expression and 198 proteins 
exhibited decreased expression following LGTV infection. Two hundred and sixty-
five of the proteins identified (54.5%) had orthology to proteins of known function 
from a variety of eukaryotes. 
The LFQ proteomic analysis was used to identify global protein expression 
of ISE6 cells at different time points (early to late) following LGTV infection. More 




differential proteomic analysis (486). After characterizing proteins with altered 
expression (a total of 70 I. scapularis pathways with protein expression change) 
following LGTV infection at each time point, a comparison of pathways with 
fluctuating protein changes following LGTV infection in early and late time points 
was completed. In addition, changes in lysine acetylation of ISE6 proteins, 
specifically histones, following LGTV infection and/or UV-LGTV treatment were 
identified at early and late time points. Protein/pathway and modification changes 
provide insight into possible cellular components that may be involved with TBF 
infection.  
3.4.1 Differential proteomics: Impact of LGTV infection on signaling in ISE6 cells 
Several proteins were identified in the notch and mTOR signaling pathways. 
The histone deacetylase 1,2,3 (ISCW007830-PA) exhibited decreased expression 
in LGTV and UV-LGTV samples. Several studies [111, 112] suggest a link between 
herpesvirus infection and gene regulation through with the binding of viral proteins 
to histone deacetylases [112].  We test that LGTV infection may impact the 
regulation of ISE6 genes via effects on histone deacetylase. In other systems, it 
has been shown that histone deacetylase can act as a co-repressor in the notch 
signaling pathway. The 40S ribosomal protein S6 (ISCW024315-PA) and Mo25 
(ISCW004710-PA) exhibited increased expression in LGTV cells. These proteins 
are members of the mTOR signaling pathway, which has been implicated in human 
cytomegalovirus (HCMV) infection in mammalian cells [113, 114] and DENV 
infection in A. aegypti mosquitoes [115]. Increased expression of Mo25 may reflect 




in translation to maintain growth of the infected cell or facilitate LGTV replication. 
Manipulation of mTOR signaling has been noted with WNV infection in mammalian 
systems [116]. The calcyclin-binding protein CacyBP (ISCW013691-PA) known to 
function in the Wnt signaling pathway in other systems, had increased expression 
in UV-LGTV-treated cells and decreased expression in LGTV-infected ISE6 
samples. Our observation suggested an increase in proteolysis following virus 
treatment since the Wnt pathway is associated with the Ca2+-dependent, ubiquitin-
mediated proteolysis pathway. Future investigations regarding roles of post-
translational modifications in regulating signaling pathways following tick-borne 
flavivirus infection is necessary.  
3.4.2 Differential proteomics: ISE6 anti-viral responses perturbed by LGTV 
infection 
Recently, the piwi-interacting RNA (piRNA) pathway has been implicated in 
the antiviral response of mosquitoes [117] and tick I. scapularis IDE8 cells [118]. 
Esther et al identified three paralogs (ISCW015916, ISCW0021130, and 
ISCW011768) of the tick I. scapularis argonaute (aubergine) protein as antiviral 
factors to LGTV infection. The I. scapularis aubergine protein possesses the paz 
and piwi domains [119] associated with RNA binding. Homologs of these proteins 
were not identified in this study, although a homolog of argonaute (AUB; 
ISCW011373-PA) was identified that exhibited increased expression in both LGTV 
and UV-LGTV ISE6 cells and may play an antiviral role in LGTV infection.  
Histone (H2A) is involved in DNA binding and chromatin packing of DNA, 
and therefore likely has a role in gene regulation and downstream host protein 




(ISCW004478-PA) exhibited increased expression in LGTV-infected ISE6 cells. 
H2A also had increased expression during DENV infection in HUH7 liver cells and 
binds with the capsid protein to inhibit nucleosome formation in these human cells 
[120]. This protein has also been found to bind antisense RNA [121], also 
suggesting a possible anti-pathogen role as a result of changes in gene regulation.  
The proteasome subunit alpha type protein (ISCW021572-PA) exhibited 
increased expression in LGTV samples and the 20S proteasome, regulatory 
subunit alpha type PSMA7/PRE6 (ISCW007139-PA) had increased expression in 
both LGTV and UV-LGTV samples. These proteins are subunits of the 
proteasome-associated 20S core particle and may exert antiviral roles through 
proteolysis and transcriptional regulation. Protein subunits of the proteasome have 
been shown to play a role in HCV internal ribosome entry site (IRES)-mediated 
translation [122] and may also interact with the HIV protein TAT and HBV protein 
HBX [123, 124]. 
3.4.3 Differential proteomics: Role of actin polymerization in ISE6 cells following 
LGTV infection 
Decreased expression of actin was observed in both LGTV-infected and 
UV-LGTV-treated samples. Cofilin (CFN; ISCW006326-PA), an actin-
depolymerizing factor, exhibited decreased expression in these samples. CFN was 
also identified in a proteomic study of HCV-infected HUH7.5 cells [56]. Actin 
polymerization is involved with formation of actin stress fibers, a process that may 
facilitate vacuole formation [125] and mammalian neuronal cell entry of Japanese 
encephalitis virus [126]. UV-LGTV-treated cells exhibited increased expression of 




RHOGDI has been implicated in actin depolarization [127] and showed increased 
expression in HCV-infected HUH7.5 cells [56] at an early (12 hpi) infection time 
point. ACTN showed increased expression in HUH7.5 cells at early (24 hpi) and 
intermediate (48 hpi) time points post HCV infection and increased expression in 
UV-HCV-treated cells at a late (72 hr) time point. In the present study, we observed 
increased expression of ACTN in UV-LGTV samples at the 36 hpi time point. In 
addition to crosslinking actin fibers and facilitating filament assembly, ACTN been 
shown to bind the HCV nonstructural proteins NS3 and NS5 [110, 128]. We 
hypothesize that this protein may assist LGTV cell entry in ISE6 cells. 
3.4.4 Differential proteomics: Maintenance of metabolism in ISE6 cells following 
LGTV infection 
The proteins acetyl-CoA acetyltransferase (ACAT1; ISCW016117) and 
aldehyde dehydrogenase 4A1 (DP5CD; ISCW015982) exhibited increased 
expression in LGTV-infected cells. These enzymes operate upstream of the TCA 
cycle and are associated with the production of acetoacetyl-CoA and pyruvate, 
respectively during cellular metabolism. This result suggested an increase in 
acetyl-CoA production following viral infection. Interestingly, citrate synthase (CS; 
ISCW009586) showed decreased expression following LGTV infection and may 
reflect a reduction of TCA protein activity late in LGTV infection. We observed a 
decrease in expression of fumarate hydratase (FH; ISCW020593) that may also 
similarly reflect reduction of TCA protein activity late in LGTV infection. The 
increased expression of MDH2 (ISCW003528), a protein involved in the final steps 
of the TCA cycle, may produce an increase in oxaloacetate, S-malate, and NADH 




ISCW020196) may increase fumarate, also involved in the final steps of the TCA 
cycle. ACAT1, DP5CD, MDH2, and FAH may aid in maintaining the TCA cycle late 
in LGTV infection. In parallel, these observations suggest an impact of LGTV on 
the TCA cycle at 36 hours post infection that may be linked to replication of the 
virus. 
Our observation of a decrease in expression of fructose-bisphosphate 
aldolase (ALDOA), glyceraldehyde-3-phosphate dehydrogenase (GADH), 
aldehyde dehydrogenase family 7 member A1 (ALDH3A2), and pyruvate kinase 
(PKLR) in LGTV-infected and UV-LGTV-treated cells, suggested an impact of 
LGTV on glycolytic processes. This finding was at odds with that of Patramool et 
al 2011, who observed that DENV-infected C6/36 A. albopictus cells [64] exhibited 
increased glycolysis. The study of Tchankouo-Nguetcheu et al identified an 
increased expression of glycolytic proteins in the in vivo midgut tissues of DENV-
infected A. aegypti [65]. Diamond et al 2010 also identified members of the 
glycolysis pathway that exhibited increased expression at early to intermediate 
time points (i.e., prior to peak release of infectious virus) following HCV infection, 
but not at the late (during and following peak release of virus from the cell) time 
point [56]. Collectively, these data suggest the possible increase in glycolysis at 
early to intermediate time points post flaviviral infection, but a decrease in 
glycolysis at later time points.  
3.4.5 Differential proteomics: Glutaminolysis associated with LGTV replication 
Glutaminolysis can produce an alternative energy source for the cell by 




expression of proteins associated with glutaminolysis suggested that LGTV 
infection in ISE6 cells may stimulate glutaminolysis and the production of α-
ketoglutarate, a key intermediate in the TCA cycle. Studies suggest that 
glutaminolysis is manipulated during infection in human cells by both HCMV [129, 
130] and HCV [56]. Thus, glutaminolysis and α-ketoglutarate are likely critical not 
only for maintaining the TCA cycle, but also supporting oxidative phosphorylation 
and ATP production in the infected cell. Additionally, stimulation of α-ketoglutarate 
has been shown to increase mTOR activity [131, 132], which operates in parallel 
with glutaminolysis. Chapter 4 shows an assessment of the manipulation of 
glutamate dehydrogenase (GDH) activity using inhibitory compounds with the goal 
of disrupting flaviviral infection. 
3.4.6 LFQ quantitative proteomics: Feasibility of ISE6 cells as tick neuronal models 
for neuroinvasive flavivirus pathogenesis 
 Neuronal proteins have traditionally been attractive targets for arthropod 
pest control, including ticks. The proteins identified in the I. scapularis tick 
synganglia [91] that overlap with the ISE6 proteins that are changing with LGTV 
infection, may provide an in vitro model for what may occur with the tick synganglia 
during flavivirus infection in vivo. As soon as the 115 synganglia proteins that 
overlapped with ISE6 cell proteins identified in the LGTV-ISE6 proteomic analyses 
are searched for their effect after LGTV infection, further cellular function/pathway 
analyses can be determined. Implications can then be made that these responses 





3.4.7 LFQ quantitative proteomics: Perturbed ISE6 cellular functions associated 
with acute LGTV infection 
 Biological function clusters identified the ISE6 cellular functions with 
proteins with increased or decreased expression following LGTV infection. The 
initial release of infectious LGTV occurs around 12 hpi and continuous release 
continues from 12 to 36/48 hpi, where peak virus release occurs (Chapter 1). At 
12 and 24 hpi, clusters of ribonucleotide complexes, ribosome, GTPase activity, 
and translation were implicated in LGTV infection. In combination with biological 
observation, LGTV completes the first translation of viral proteins early in acute 
infection (<12 hpi) and with cluster observations, manipulates nuclear/genetic 
functions to help aid in this task. Flavivirus proteins have been known to enter the 
nucleus during infection [120, 133, 134], so effect on ribonucleotide proteins 
(histones, histone deacetylases, etc) is imminent although poorly understood. At 
24 hpi, protein folding, unfolded protein response, glycosylation activity, 
endoplasmic reticulum (ER) involvement, RNA recognition, and 
cofactor/NAD/NADH binding were also implicated in LGTV infection. Protein 
folding and unfolding response may correlate with viral protein processing, virion 
assembly, and/or egress/transport. Glycosylation and ER involvement suggested 
the glycosylation activity of a protein that occurs in the ER right before budding into 
the Golgi apparatus, where in this case, may be a host and/or viral protein. RNA 
recognition may possibly correlate with the virus’ RNA replication and/or RNA 
genome packaging during virion assembly. Stress related responses by the cell 
were heat shock protein activity, reductase activity, and thioredoxin function at 12 




In addition, a cellular environment with reduced energy and biosynthetic 
metabolic processes was identified at 24 hpi with a cluster formed by proteins with 
decreased expression. Also, more TCA cycle and oxidative phosphorylation 
proteins with increased expression than decreased expression following LGTV 
infection were identified at 12 and 24 hpi. TCA cycle and oxidative phosphorylation 
proteins were identified with no change in expression at 36 hpi and more TCA 
cycle and oxidative phosphorylation proteins were identified with decreased 
expression than increased expression at 48 hpi. This suggested that cellular 
substrates and components used for energy (ATP) production were used up early 
(≤ 24 hpi) in LGTV infection, and may depict the cell responding/adjusting to this 
decreased-nutrient environment. The hypothesis that more ISE6 TCA cycle and 
oxidative phosphorylation proteins have decreased expression than increased 
expression following 12-48 hpi with LGTV was rejected. Only at 48 hpi was when 
this hypothesis was observed, not from 12-36 hpi. Further metabolite analyses 
need to be completed in order to provide insight, in parallel with proteomics, into 
ISE6 cell responses following LGTV infection.   
3.4.8 LFQ quantitative proteomics: ISE6 proteins with increased and decreased 
expression following acute LGTV infection reveal fluctuating cellular pathways 
3.4.8.1 Metabolic pathways 
 A heavy reliance on amino acid and carbohydrate metabolism is crucial for 
LGTV infection, not only because these pathways would produce substrates for 
virus particle or protein production, but also because they provide substrates 
necessary for maintaining cellular energy levels and health. This LFQ proteomic 




ISE6 proteins being identified in amino acid and carbohydrate pathways. With the 
majority of metabolic proteins with increased expression residing in amino acid and 
carbohydrate pathways, it may be characteristic of the amino acid supply needed 
to produce viral proteins but also necessary to provide an alternative carbon 
energy source (e.g. glutaminolysis) to ISE6 cells (glycolysis/gluconeogenesis 
found with proteins of increased expression at 24 hpi but found with proteins of 
decreased levels at 36 hpi in the differential proteomic analysis)  as acute infection 
continues. 
The second tier of metabolic pathways identified with proteins of increased 
expression were lipid, cofactors/vitamins, and xenobiotics biodegradation 
metabolism. Flavivirus production of replication complexes require lipid 
membranes and have been known to perturb lipid metabolism [59, 89, 135, 136], 
so lipid metabolism was suggested to associate with LGTV replication complex 
formation. The shift of lipid metabolic proteins with increased expression early in 
infection (12 and 24 hpi) to a decreased expression late in infection (36 and 48 hpi) 
was suggested to be characteristic of the lipids involved in viral replication 
complexes and/or for production of cellular energy. Cofactors/vitamins provide the 
substrates necessary for nucleotide and amino acid production and serve as key 
intermediates for metabolic enzymes, hence it was suggested these proteins 
involved in cofactor/vitamin metabolism early in infection (12 and 24 hpi) aid in 
providing necessary substrates for viral genome and protein production.  
 Energy metabolism, or oxidative phosphorylation and 2-oxocarboxylic acid 




in many biosynthetic processes used by the virus (e.g. viral genome replication 
complex formation and viral protein production). But they were found to be 
decreased later (24, 36, and 48 hpi) as the acute infection continues. In addition, 
three energy-associated (citrate/TCA cycle, pyruvate metabolism, and carbon 
metabolism) pathways were identified with increased protein expression early in 
infection and identified with decreased protein expression later in infection. The 
decrease in energy may be characteristic of the ISE6 cells with decreased 
substrate/intermediate levels and/or response to limit biosynthetic processes due 
to viral infection/stress response (e.g. cell survival). Similarly, glycan biosynthesis 
was increased early at 12 and 24 hpi, but decreased at 48 hpi. Glycans make up 
some receptors that flaviviruses use for targeted entry receptors but also use 
glycans as part of their viral proteins. So, increased LGTV production at 12 to 24 
hpi was directly correlated with increased glycan biosynthesis. 
3.4.8.2 Genetic information processing pathways 
 Translation, replication/repair, and folding/sorting/degradation pathways 
were the only GIP pathways identified in the LFQ proteomic analysis. However, 
proteins with increased expression residing in these pathways were suggested to 
be involved with LGTV protein production, assembly, and egress/transport. 
Proteins in the replication and repair pathway may also be increased due to 
increased DNA damage that may result from LGTV infection and potential nuclear 






3.4.8.3 Cellular processes pathways 
 Proteins identified with increased expression levels involved in the 
endocytosis pathway at 12 and 24 hpi suggest this process to be increased early 
in infection due to LGTV entering ISE6 cells via endocytosis. An increase in 
phagosome function early in infection may be characteristic of ISE6 cells 
consuming available cellular substrates to aid the increase in energy needed for 
biosynthetic processes. An increase in peroxisomes early in LGTV infection was 
presumably involved with the breakdown of substrates (e.g. fatty acids and amino 
acids) and formation of acetyl-CoA for use in energy production that may aid in 
LGTV replication complex formation, LGTV protein production, and/or cellular 
energy. A decrease in peroxisomes later in LGTV infection (36 and 48 hpi) may 
suggest that the ISE6 cell was limiting biosynthetic processes and does not need 
free substrates. An increase of lysosome function may be due to the use of this 
function to release infectious LGTV and/or due to a response to cellular stress.  
3.4.8.4 Environmental information processing pathways 
 Signaling transduction response was primarily early in LGTV infection. Only 
12 hpi revealed proteins with increased expression with signal transduction and as 
early as 24 hpi signaling became decreased. This suggested that later in infection 
that metabolic, cellular processes, and signaling all become reduced presumably 
to limit cellular biosynthetic processes and to maintain a homeostatic condition.  
3.4.9 LFQ quantitative proteomics: Histone lysine acetylation changes with LGTV 
infection and UV-LGTV treatment 
 As mentioned before, flavivirus proteins have been shown to enter the 




138]. In addition, histone levels/expressions have been shown to be manipulated 
with flavivirus infection where viral proteins have been implicated to sequester 
histone proteins [120]. It was suggested that gene regulation was manipulated via 
interactions of histones and viral proteins. The mechanism on how viral proteins 
affect histone acetylation activity yet needs to be elucidated.  
 Histones have additionally been implicated in connection with controlling 
metabolic processes by controlling transcription and subsequent translation of host 
proteins. Acetylation is a modification that activates histones and allows for more 
genetic material to be transcribed. Altered levels of acetylation of histones directly 
alters the production of cellular proteins that may be involved with key metabolic 
pathways [139, 140]. It is hypothesized that ATP-citrate synthase (ISCW009919), 
increased expression following LGTV infection at 12 hpi, provides an increase flux 
production of nuclear acetyl-CoA, a required cofactor used to acetylate lysine 
residues. In addition to nuclear acetyl-CoA levels, cytoplasmic or mitochondrial 
acetyl-CoA levels were predicted to be increased as well early in LGTV infection.  
There were a number of histones identified with increased expression 
following LGTV infection in the differential and LFQ proteomic analyses: Histone 
H2A, Histone H1/5, and Histone H4. Also, a histone deacetylase was identified 
with decreased expression following LGTV infection in the differential and LFQ 
proteomic analyses.  In addition, identified ISE6 proteins with histone 
acetyltransferase activity and acetyltransferase activity within the differential and 
LFQ proteomic studies with increased expression following LGTV infection (data 




compartments. Finally, the LFQ proteomic analysis identified histones with 
increased and decreased expressions of lysine acetylation following LGTV 
infection. Specifically, this included Histone H3 and Histone H4. From this 
information, it may be possible that LGTV infection may affect activity of ISE6 
histones, however the effect on histone levels/activity on ISE6 metabolic enzyme 
production/activity remains unknown.  
3.5 LGTV-ISE6 PROTOMIC ANALYSES SUMMARY 
The differential proteomic analysis provided an initial look at cellular 
pathway/function changes associated with LGTV infection, specifically at peak 
LGTV replication. The LFQ proteomic analysis provides an additional validation of 
ISE6 proteins identified from the differential proteomic analysis (with additional 
ISE6 proteins), quantitated levels of ISE6 proteins following four different time 
points following LGTV infection, identification of fluctuating cellular pathways from 
early to late acute LGTV infection, and lysine acetylation changes of ISE6 proteins 
following LGTV infection. In the future, additional post-translational modifications 
(glycosylation, phosphorylation, and methylation) can be searched with the same 
LFQ datasets to identify more modifications on ISE6 proteins associated with 
LGTV infection. 
Identification of 486 tick proteins from the differential proteomic analysis and 
579 tick proteins from the quantitative proteomic analysis (301 ISE6 proteins 
overlap) provided an extensive proteomic characterization of the ISE6 cell, at peak 
LGTV release and 12-48 hpi acute LGTV infection. In combination with ISE6 




in all three proteomic analyses, 211 overlap with the differential proteomic analysis, 
270 overlap with the quantitative proteomic analysis, and 386 overlap with two or 
more of the three ISE6 protein datasets. For the first time, these analyses provided 
tick proteome responses to a TBF infection. 
The identification of these proteins and their cellular pathways provide a 
critical resource to improve understanding of the I. scapularis proteome, improve 
gene annotations, and facilitate further studies in the tick cell culture system. In 
addition, to contribute to an improved understanding of flavivirus-I.scapularis 
interactions, the differential and LFQ proteomic analyses provide proteins and 
pathways that were changing in association with LGTV. The present study is an 
important first step toward identifying tick proteins tied to LGTV replication and can 
be used for anti-tick vaccines and/or for therapeutic screening to disrupt tick-borne 
flavivirus transmission. Further understanding of protein function can also be 
achieved using approaches such as IFA, targeted mass spectrometry, small 
molecule in vitro assays, and RNAi. Chapter 4 will go more into depth of the small 
molecule/RNAi in vitro assays and the proteins/cellular pathways that were 










3.6 FIGURES, TABLES, AND LEGENDS 
 
Fig 1. Summary of differential proteomic analysis of LGTV-infected and UV-
LGTV-treated I. scapularis ISE6 cells. After whole cell sample harvest of treated 
ISE6 cells, cell pellet samples were subjected to lipid removal, protein precipitation, 
peptide denaturation, and tryptic digest of peptides. Samples were prepared for 
the separation phase (nano LC) by injection, using electrospray ionization (ESI). 
Mass analysis of the precursor ion spectra was completed, followed by the second 
fragment ion MS/MS dimension for downstream peptide identification. Two group 
and three group statistical analyses with ISE6 cells treated with virus (LGTV), UV-
inactivated virus (UV-LGTV), and no virus (mock) were compared utilizing a 
proteomic/metabolite pipeline, Omics Discovery Pipeline (ODP). After 
identification of significantly-changing (p < 0.05) MS peaks from LGTV-infected 
and UV-LGTV-treated ISE6 cells, corresponding peptides were identified to 
specific I. scapularis proteins (VectorBase I. scapularis WIKEL genome IscaW1.2 
predicted protein set database). ISE6 proteins were then subject to protein function 









Table 1. Summary of analyses used to identify proteins from LGTV-infected 
and UV-LGTV-treated ISE6 cell samples 
Processing Step No MS peaks/Peptides/Proteins per Treatment 












































The ODP was used 
to calculate a P 
value based on the 
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Δ fwd-rev scored > 
1 with parent 
charges +1 and +2 
 
Δ fwd-rev score > 2 
with parent charges 









Final List of 
MS peaks 
Removal of 
replicate MS peaks 










Number of Peptides 
Peptides Number of unique 
peptides 
772  893  315  821  
Number of Proteins 




374  409  201  395  




bAfter normalization of MS peaks in each treatment group (LGTV, UV-LGTV, and 
mock), t-test and ANOVA analyses were performed in the Significance Test step 
of the ODP. 
cSpectrum Mill peptide score and % scored peak intensity are two criteria utilized 
to identify peptides from in silico database searches. See material and methods 
section for more details. 
dSpectrum Mill reverse database search was completed to account for possible 
false positives when identifying peptides from in silico database searches. See 
material and methods section for more details. 
e≥1 peptide match to a VectorBase gene model predicted peptide sequence was 












Fig 2. Hierarchical clustering of MS peak profiles of ISE6 cells treated with 
LGTV, UV-LGTV, and mock. M1-5, mock1-5 samples; LGTV1-5, LGTV-infected 
samples 1-5, and UV-LGTV1-5, UV-LGTV samples 1-5. Vertical rows depict n=5 
biological replicates. Horizontal rows correspond to significant MS peaks of 
peptides/proteins at 36 hours post infection/treatment. Clustering analysis shows 
common patterns of protein expression profiles shared between the three 
treatment groups. The red-green color scale denotes the Z score fold change with 









Fig 3. Identification and expression of ISE6 cell proteins following treatment 
to LGTV, UV-LGTV, and mock. (A) Four statistical analyses were performed 
using the ODP output. This included a three-way ANOVA of treatment groups 
LGTV, UV-LGTV, mock and two-way t-test comparing the LGTV vs. mock, UV-
LGTV vs. mock, and LGTV vs. UV-LGTV samples. The Venn diagram shows 
unique and common ISE6 protein identifications from these datasets. (B) Venn 
diagrams showing the numbers of ISE6 proteins identified as exhibiting increased 
or decreased expression following treatment to LGTV or UV-LGTV unique or 










Fig 4. ISE6 proteins identified in KEGG pathways with differential expression 
following LGTV, UV-LGTV and mock treatment. (A) Total number of ISE6 cell 
proteins categorized by treatment and change in expression 
(increase/decrease/no change). Total number of proteins showing (B) increased 
expression, (C) decreased expression, and (D) no change in expression following 
LGTV infection and UV-LGTV treatment as compared to mock-treated cells and in 
LGTV-infected cells as compared to UV-LGTV-treated cells. Proteins were 
categorized by the KEGG classes for cellular function: metabolism, genetic 
information processing (GIP), environmental information processing (EIP), cellular 









Fig 5. ISE6 protein orthology and cellular function distribution of proteins 
found in KEGG pathways and modules. (A) Ixodes scapularis ISE6 proteins with 
KEGG-mapped orthologs (or KEGG orthology [KO]) help to identify cellular 
pathways in I. scapularis (genome.jp/kegg/ko). To be identified in a KEGG pathway, 
KO is required. ISE6 proteins with KO and not identified in I. scapularis (KEGG) 
pathways are also included. (B) Percent cellular function distribution of proteins 










Fig 6. Summary of differentially-expressed ISE6 proteins without identified 
pathways. Expression of ISE6 proteins with (A) or without (B) orthology and no 
identified pathways. Refer to S2 Table for more specifics on the proteins. Red 
dotted line denotes differentially-expressed proteins in LGTV-infected ISE6 cells 







Fig 7. ISE6 proteins associated with the TCA cycle and glutaminolysis. ISE6 
glutaminolysis and mTOR signaling proteins altered with LGTV infection are shown.  
GDH denotes glutamate dehydrogenase enzymes and Glase denotes glutaminase 
enzymes. ISCWxxxxxx denotes corresponding VB accession ID for corresponding 
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Fig 8. Citrate cycle showing ISE6 proteins that exhibited 
increased/decreased expression following treatment to LGTV and UV-LGTV. 
The enzymes are indicated with KEGG abbreviated nomenclature and the 
corresponding substrates are shown in circles. * denotes proteins identified in this 
study. Dotted lines denote indirect involvement with production. The increased 
expression of malate dehydrogenase (MDH2) was unique to LGTV-treated cells 
while increase in the expression of acetyl-CoA acetyltransferase 1 (ACAT1), delta-
1-pyrroline-5-carboxylate dehydrogenase (ALDH4A1), glutamate dehydrogenase 
(GLUD1), and fumarylacetoacetase (FAH) was common to cell samples following 
LGTV infection and UV-LGTV treatment. Decreased expression of citrate synthase 
(CS) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was observed in 
LGTV-treated cells and decreased expression of fumarate hydratase (FH), 
aldolase A/B/C fructose-bisphosphate (ALDOA/B/C), and aldehyde 
dehydrogenase 2/1B1/3A2 family protein (ALDH2/1B1/3A2) was observed in both 
LGTV-infected and UV-LGTV--treated cells. ATP citrate lyase (ACLY), aconitase 
(ACO), isocitrate dehydrogenase 2/3a (IDH2/3a), oxoglutarate/alpha-ketoglutarate 
dehydrogenase complex (OGDH/DLST), succinyl-CoA synthetase alpha/beta 
subunit (LSC1/2), succinate dehydrogenase flavoprotein subunit (SDHA), 
pyruvate kinase (PK), enolase 1/2/3 (ENO1/2/3), and aldehyde dehydrogenase 









Fig 9. Number of ISE6 proteins corresponding to orthologous proteins 
identified in proteomic analyses of flavivirus-host systems. Corresponding 
percentages correspond to the number of ISE6 orthologs identified with orthologs 
identified in: α S5 Fig, S7 Fig, and S11 Fig of Khadka et al [110]; µS2 Table of 
Tchankouo-Nguetcheu et al [65]; βTables 1 and 2 of Pastorino et al [109]; ΔS1 






Fig 10. ISE6 proteins with increased expression associate with pathways for 
protein production, transport, assembly, and proteolysis. The ISCW 
accession numbers corresponding to proteins identified with increased expression 
in LGTV-infected and UV-LGTV-treated cells are shown (KEGG abbreviated 
nomenclature provided as well if available in parentheses). The schematic 
presents potential mechanisms for LGTV-induced perturbation and increase in cell 
protein expression. Underlined proteins denote ISE6 proteins exhibiting increased 
expression following flavivirus infection not identified before. “Fld, Srt, & Deg” is 
the folding, sorting, and degradation KEGG pathway. ** denotes ortholog in human 
[56]; + denotes human ortholog showing increased expression following HCV 
infection; -- denotes human ortholog showing decreased expression following HCV 













Fig 11. Summary of quantitative proteomic analysis of LGTV-infected and 
UV-LGTV-treated I. scapularis ISE6 cells. After whole cell sample harvest of 
treated ISE6 cells, cell pellet samples were subject to lipid removal, protein 
precipitation, peptide denaturation, and tryptic digest of peptides. Samples were 
prepared for the separation phase (nano LC) by injection, using electrospray 
ionization (ESI). Mass analysis of the precursor ion spectra was completed, 
followed by the second fragment ion MS/MS dimension for downstream peptide 
identification. Two group and three group statistical analyses with ISE6 cells 
treated with virus (LGTV), UV-inactivated virus (UV-LGTV), and no virus (mock) 
were compared utilizing a proteomic/metabolite program InfernoRDN. After 
identification of significantly-changing (p < 0.05) MS peaks from LGTV-infected 
and UV-LGTV-treated ISE6 cells, corresponding peptides were identified to 
specific I. scapularis proteins (VectorBase I. scapularis WIKEL genome IscaW1 
predicted protein set database from UniProt). ISE6 proteins were then subject to 
protein function and pathway analyses (via KEGG). See materials and methods 










Table 3. Summary of analyses used to identify proteins from LGTV-infected 
and UV-LGTV-treated ISE6 cell samples in LFQ analysis. 
Processing Step No. Proteins per Time point 
 Description 12 hpi 24 hpi 36 hpi 48 hpi 
Total number of 
proteins observed 
LC-MS raw data were 
aligned and normalized 
using Inferno RDNa and 
uploaded to MaxQuant 
for protein ID output. 
960 1,023 991 1,100 
 
Total number of 
proteins observed 




 896 948 929 1,026 
Total number of 
proteins identified in 
at least three out of 
five biological 
replicate samples 
Of three treatments 
(LGTV, UV-LGTV, and 
mock), protein identified 
in at least three out of 
five biological replicates 
of at least one 
treatment group 
466 476 478 488 
Proteins with Increased Expression 
LGTV infection  34 2 2 4 
LGTV infection and 
UV-LGTV treatment 
 50 74 8 4 





 33 1 1 4 
Proteins with Decreased Expression 
LGTV infection  23 59 15 74 
LGTV infection and 
UV-LGTV treatment 
 3 10 1 3 
UV-LGTV treatment  6 4 3 3 
aInferno RDN (http://omics.pnl.gov/software/infernordn) encompasses R package 
to complete t-test and ANOVA analyses.  
bUploaded, searched Uniprot protein database corresponding to the I. scapularis 
IscaW1 genome assembly has included contaminant peptide sequences to help 
identify non-I. scapularis peptides. 
cMaxQuant option for reverse database search was selected in combination with 







Fig 12. ISE6 proteins identified in quantitative proteomic analysis. ISE6 
proteins were identified in (A) at least three out of five biological replicates of at 
least one treatment group (LGTV, UV-LGTV, and mock) and in (B) statistically-







Fig 13. Identification of ISE6 cell proteins following LGTV infection and UV-
LGTV treatment. For 12 (A), 24 (B), 36 (C), and 48 (D) hpi time points, four 
statistical analyses were performed. This included a three-way ANOVA of 
treatment groups LGTV, UV-LGTV, mock and two-way t-test comparing the LGTV 
vs. mock, UV-LGTV vs. mock, and LGTV vs. UV-LGTV samples. The Venn 












Fig 14. Comparative proteomics analysis identifies ISE6 proteins in I. 
scapularis synganglia tissue. ISE6-LGTV protein identifications (*/**Grabowski 
et al differential and LFQ) and I. scapularis synganglia protein identifications 













Table 4. Summary of proteins used from LGTV-infected and UV-LGTV-treated 
ISE6 cell samples for LFQ analysis in DAVID functional clustering and KEGG 
pathway analyses. 
Processing Step No. Proteins per Time point 
 Description 12 hpi 24 hpi 36 hpi 48 hpi 
Total number of 
proteins searched 




LGTV infection and/or 
UV-LGTV treatment 
128 177 54 104 
Total number of 
proteins searched 
by DAVID 
DAVID will only search I. 
scapularis proteins with 
orthologya 
100 135 37 75 
Total number of 
proteins not 
searched by DAVID 
I. scapularis proteins with 
no orthologya 
28 42 17 29 
Total number of 
significant, biological 
function clusters of 
all DAVID searched 
proteins 
Enrichment (E)b score of 
≥ 1.3 is equal to a ≤ 0.05 
p value 
5 8 0 2 
Total number of 
significant, biological 
function clusters of 
all DAVID searched 
proteins 
Searched with proteins of 
increased expression 
following LGTV infection 
5 9 0 1 
Total number of 
significant, biological 
function clusters of 
all DAVID searched 
proteins 
Searched with proteins of 
decreased expression 
following LGTV infection 
0 2 0 0 
Total number of 
proteins mapped to 
KEGG pathways 
DAVID will only map 
proteins with isc-specificc, 
KEGG pathways 
33 34 12 18 
aOrthology refers to proteins with corresponding KEGG Orthology. 
bHigher the E score the increased strength or confidence of the cluster of biological 
function occurring with the included proteins. 
cProteins with KEGG Orthology have mapped I. scapularis (isc) pathways or no 
mapped isc pathways. Proteins with KEGG Orthology and no mapped isc 









Table 5. Summary of DAVID functional clustering of proteins with increased 
or decreased expressions following LGTV infection of ISE6 cell samples 
from LFQ analysis. 
Time point ClusterΔ Cluster 
Summary 











No Clusters  




   
 Cluster 3 thioredoxin function, 
homeostatic 
response 
   





   










Cluster 1 RNA recognition and 
nucleotide binding 
 Cluster 2 protein folding and 
unfolded protein 
response 
 Cluster 2 ATP, 
nucleotide/ribonucle
otide, and nitrogen 
biosynthetic/metabol
ic processes. Cation 
transmembrane 
transporter activity. 
 Cluster 3 RNA recognition and 
nucleotide binding 
   
 Cluster 4 glycosylation activity 
and ER involvement 
   




   
 Cluster 6 nucleotide and 
ribonucleotide 
binding 
   
 Cluster 7 GTPase and binding 




   
 Cluster 8 thioredoxin function; 
homeostatic 
response 
   
 Cluster 9 cofactor, NAD, and 
NADH binding 


















No Clusters  
ΔAll clusters had an Enrichment score of ≥1.3 and cluster summaries had a p 





Fig 15. ISE6 pathway change following acute LGTV infection. Pathways with 
proteins of increased (A) and decreased (B) expression are identified across 12, 
24, 36, and 48 hpi. The Venn diagram shows unique and common ISE6 pathways 












Fig 16. ISE6 pathway change following acute LGTV infection at specific time 
points. Pathways with proteins of increased and decreased expression are 
identified within each 12, 24, 36, and 48 hpi time point. The Venn diagram shows 
unique and common ISE6 pathways with proteins of increased and/or decreased 












Fig 17. Specified ISE6 pathway change following acute LGTV infection at 
specific time points. Pathways with proteins with increased or decreased 
expression are identified at 12, 24, 36, and 48 hpi. Cellular functions categorize 
the pathways listed and are as follows: Metabolism, Genetic Information 
Processing (GIP), Cellular Processes, Environmental Information Processing 
















Fig 18. Citrate cycle showing ISE6 proteins that exhibited 
increased/decreased expression at specific time points following treatment 
to LGTV infection and UV-LGTV treatment. The enzymes are indicated with 
KEGG abbreviated nomenclature and the corresponding substrates are shown in 
circles. * denotes proteins not identified in this study at that specific time point. 
Dotted lines denote indirect involvement with production. Enzymes listed include: 
malate dehydrogenase (ISCW003528; MDH2), citrate synthase (ISCW009586; 
CS), ATP citrate lyase (ISCW009919; ACLY), aconitase (ISCW013457; ACO), 
isocitrate dehydrogenase 2/3a (ISCW001977, ISCW004116; IDH2/3a), 
dihydrolipoamide acetyltransferase (ISCW008731; DLST), oxoglutarate/alpha-
ketoglutarate dehydrogenase complex (ISCW003165; OGDH), succinyl-CoA 
synthetase alpha/beta subunit (ISCW011750; LSC2), succinate dehydrogenase 
flavoprotein subunit (ISCW000555; SDHA), fumarate hydratase (ISCW020593; 
FH), dihydrolipoamide succinyltransferase (ISCW013308; DLAT), pyruvate 
dehydrogenase (ISCW019126; PDHA), and branched chain alpha-keto acid 







Fig 19. ISE6 proteins with lysine acetylation changes following LGTV 
infection and UV-LGTV treatment. ISE6 proteins with increased or decreased 
expression of lysine acetylated residues is shown (number listed in parentheses). 
Red denotes proteins with increased expression of acetylated peptides and blue 
denotes proteins with decreased expression of acetylated peptides following LGTV 


















CHAPTER 4: FUNCTIONAL SMALL MOLECULE AND RNA INTERFERENCE 
ASSAYS TO IDENTIFY TICK PROTEINS INVOLVED IN LGTV INFECTION 
 
4.1 INTRODUCTION  
 Grabowski et al (in review) and Chapter 3 provided a set of I. scapularis 
ISE6 proteins differentially-expressed following LGTV infection and identified 
metabolic processes that may be involved in LGTV infection [87]. Most ISE6 
proteins with increased expression were identified as members of amino acid 
metabolism, carbohydrate metabolism, vitamins/cofactor metabolism, lipid 
metabolism, nucleotide metabolism, and folding/sorting/degradation pathways. 
Here, we investigate the hypothesis that ISE6 amino 
acid/carbohydrate/vitamin/cofactor/lipid/nucleotide metabolic enzymes and 
folding/sorting/degradation proteins with increased expression following LGTV 
infection were involved in LGTV infection. In addition to identifying protein 
expression change following LGTV infection, protein modification change was 
identified with lysine acetylation change following LGTV infection in Chapter 3. 
Increased expression of lysine acetylated histones were identified with LGTV 
infection. From this observation, it was hypothesized that an increase in lysine 
acetylation of histones increased LGTV infection in ISE6 cells. Currently, there is 
limited knowledge on how tick proteins, specifically expression and modification 
levels, effect the LGTV life cycle.
viii 
This chapter investigated function of selected proteins identified from 
Chapter 3 and from Grabowski et al [87]) on LGTV infection by employing two 
complementary approaches—small molecule compound and RNAi assays. Ten 
genes of interest were selected for RNAi transcript knockdown and functional 
studies based on strength of protein identification and orthology. The ten selected 
genes were fumarylacetoacetase (ISCW020196; Fumar; amino acid metabolism), 
endoplasmic reticulum protein 29 (ISCW018425; ERP29; folding, sorting, and 
degradation), 1-pyrroline-5-carboxylate dehydrogenase (ISCW015982; DPCD; 
amino acid metabolism), pantetheine hydrolase (ISCW004822; CNHydro; 
metabolism of cofactors and vitamins), malate dehydrogenase (ISCW003528; 
MDH2; carbohydrate metabolism), poly [ADP-ribose] polymerase (ISCW019519; 
PARP; replication and repair), UMP-CMP kinase (ISCW012446; CUKinase; 
nucleotide metabolism), acetyl-CoA acetyltransferase (ISCW016117; ACAT1; 
carbohydrate, lipid, amino acid, and terpenoids/polykeytides metabolism), 
hypothetical protein (ISCW011195; Hypo195; unknown function), and hypothetical 
protein (ISCW020576; Hypo576; unknown function). Transcripts for these genes 
of interest were confirmed in ISE6 cells and female I. scapularis. Transcript 
knockdowns were conducted and the effect on LGTV genome replication and 
infectious virus release was evaluated.  
Information from these studies could be used to identify tick proteins to 
control TBFs. Host factors have been used to develop or identify therapeutics 
against flavivirus infection [141-144] and this study provides new proteins for 




4.2 MATERIALS AND METHODS 
4.2.1 Cell and virus culture 
 Cells and virus stocks were prepared as described in Chapter 2, Section 
2.2.1. 
4.2.2 LGTV infection in ISE6 cells and measurement of infectious LGTV  
 LGTV infection of ISE6 cells and measurement of infectious LGTV was 
completed as described in Chapter 2, Section 2.2.3.  
4.2.3 Compound and cell viability assays 
 Trichostatin A (TSA; Sigma-Aldrich; T8552) and Oligomycin A (OligoA; 
Sigma-Aldrich; 75351) were re-suspended in DMSO to a final concentration of 10 
mM and working concentrations of 0.01, 0.1, 1, and 10 µM concentrations. 
Nicotinamide (NAM; Sigma-Aldrich; 72340) was re-suspended in cell media to a 
final concentration of 100 mM and working concentrations of 100, 1,000, 10,000, 
and 100,000 µM concentrations. Famotidine (FAMO; Sigma-Aldrich; F6889) was 
re-suspended in DMSO to a final concentration of 10 mM and working 
concentrations of 0.1, 1, 10, 100, 1,000, and 10,000 µM concentrations. 
Hexachlorophene (Hexa; Sigma-Aldrich; 45526) was re-suspended in DMSO to a 
final concentration of 100 mM and working concentrations of 0.1, 1, 10, 100, 1,000, 
and 10,000 µM concentrations. Epigallocatechin (EGC; Sigma-Aldrich; E3768) 
was re-suspended in DMSO to a final concentration of 10 mM and working 
concentrations of 0.1, 1, 10, 100, 1,000, and 10,000 µM concentrations. 




to a final concentration of 100 mM and working concentrations of 0.1, 1, 10, 100, 
1,000, and 10,000 µM concentrations. 
 96 well plates were pretreated with 0.01% Poly-L-Lysine (Sigma Aldrich; 
P4832) and allowed to air dry in a biosafety cabinet. Plates were separately 
seeded with ISE6 and Vero cells and incubated for 24 hours to final cell density of 
~1 x105 cells/96 well, and cells were infected with LGTV passage 4, MOI of 10, 
and LGTV passage 4, MOI of 3, respectively (TSA, OligoA, NAM, and FAMO were 
screened in ISE6 and Vero cells; Hexa, EGC, and ECG were screened only in 
ISE6 cells). Following virus adsorption, compounds diluted in DMSO (1% of total 
overlay media) or in cell media were added to cells (0 hpi) and cells were incubated 
at 37°C. Culture supernatants were collected at 36 hpi and used to quantify LGTV 
replication by plaque assay, and 1:10 dilution of alamarBlue reagent (AbD Serotec; 
BUF012A) with fresh media was placed onto infected ISE6 and Vero cells for 12 
and 2 hours for subsequent cell viability readings. Fluorescence (excitation at 
560nm, emission at 590 nm) was measured at 12 and 2 hours post addition using 
a Molecular Devices SpectraMax M5 plate reader coupled with SoftMax Pro v4.8 
software to acquire cell viability readings (see Chapter 2, Section 2.2.5). Mock-
treated (pre treated cell media) cells underwent the same treatment but without 
LGTV infection. Two biological replicates were conducted for each experiment and 







4.2.4 Measurement of ISE6 cell concentrations 
 To equalize cell numbers between biological replicates and between 
treatment groups prior to protein extraction, the concentration of cells in each 
sample (cells/ml) was estimated. See Chapter 2, Section 2.2.2 for more detail. 
4.2.5 RNA isolation and cDNA synthesis 
 Single I. scapularis female ticks (collected from Tippecanoe State Park, 
Winimac, IN; October 29, 2013) were flash frozen in liquid N2 and ground in TRIzol 
reagent (Invitrogen; 15596-026) using mortar and pestle and RNA was extracted 
as per manufacturer instructions. RNA was isolated from ISE6 cells (passage 96-
100) grown in 96 well plates using Buffer RLT lysis buffer from the RNeasy mini kit 
(Qiagen; 74104) and processed according to kit instructions. cDNA from RNA 
samples using the iScript cDNA synthesis kit (BIORAD; 170-8891). Thermocycler 
conditions used for cDNA synthesis were as follows: 25°C for 5 minutes, 42°C for 
50 minutes, and 85°C for 5 minutes. 
4.2.6 Transcript expression 
 Primers ranging from 300-607 bp in length were designed for genes of 
interest using Primer3 software [145] in the NCBI Primer-BLAST tool 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). cDNA template derived from 
female I. scapularis or ISE6 cells, primers (25 nmole; Table 1), and Phusion high-
fidelity PCR master mix with HF buffer (NE Biolabs; M0531S) were used for cDNA 
amplification. The following thermocycler conditions were used: 94°C for 5 minutes, 
32 cycles of 94°C for 30 seconds/58°C for 30 seconds/72°C for 2 minutes, and 




expected sizes were confirmed and excised using the Qiagen gel extraction kit 
(Qiagen; 28704). cDNA samples were sequenced (using forward primers from 
Table 1) at the DNA Sequencing Low Throughput Laboratory (Purdue Genomics 
Core Facility; Purdue University) to confirm identity of genes of interest from both 
I. scapularis female ticks and ISE6 cells.  
4.2.7 Synthesis of dsRNA for genes of interest 
 cDNA template and primers with T7 promotor sequence (50 nmole; Table 
2) were used in the same manner as in Section 4.2.6 but with the following 
thermocycler conditions: 94°C for 5 minutes, 5 cycles at 94°C for 30 seconds/58°C 
for 30 seconds/72°C for 2 minutes (anneals the gene-specific section of the primer 
to form some PCR product), next 27 cycles at 94°C for 30 seconds/68°C for 30 
seconds/72°C for 2 minutes, and final extension at 72°C for 7 minutes (anneals 
the entire primer site for further amplification of PCR product). PCR product of 
amplified cDNA with T7 promotor sequence was used to create dsRNA with the 
MEGAscript RNAi synthesis kit according to Barry et al [146].  
4.2.8 Transfection of ISE6 cells with dsRNA 
 OptiMEM Reduced Serum Medium, Glutamax supplement (Invitrogen; 
51985-034) and xtremeGENE siRNA transfection reagent (Roche; 4476093001) 
were used in the transfection mix according to Barry et al [146]. ISE6 cells (~1 x 
104-5) were grown for 48 hours using 96 well flat-bottom cell culture plates (pre 
treated with poly-L-lysine), half of the media volume was removed, transfection mix 
(xtremeGENE siRNA transfection reagent, OptiMEM, and 10 ng dsRNA) was 




was completed. After 60 hours post transfection, media/transfection mix was 
removed and resazurin salt (alamarBlue reagent) media was placed on the cells 
for 12 hours growth before fluorescent measurement for cell viability reading. In 
parallel, media/transfection mix was removed after 60 hours post transfection and 
RNA was extracted from cells with Buffer RLT for further analysis with qRT-PCR 
to confirm transcript knockdown of genes of interest. 
 To measure transcript knockdown effect on LGTV genome replication, 
media/transfection mix was removed after 60 hours post transfection, cells were 
treated with LGTV, cells were rinsed 3 x PBS, fresh media was placed on the cells 
for 12 hpi, and RNA was extracted from cells with Buffer RLT for further analysis 
with qRT-PCR. To measure transcript knockdown effect on LGTV replication after 
knockdown, media/transfection mix was removed after 60 hours post transfection, 
cells were treated with LGTV, cells were rinsed 3 x PBS, fresh media was placed 
on the cells for 16 hpi, and media was collected for further analysis with plaque 
assays. To measure transcript knockdown effect on LGTV replication during 
knockdown, cells were first treated with LGTV, cells were rinsed 3 x PBS, 
media/transfection mix was placed on the cells for 60 hours post transfection, and 
media/transfection mix was collected for further analysis with plaque assays. 
4.2.9 Cell viability measurement 
 Resazurin sodium salt solution (27.5 mM; 0.346 g in 50 mL 1XPBS) was 
used in a 1:100 working stock in media for each cell viability experiment. 
Fluorescent cell viability readings were obtained as described in section 2.2.5 and 




4.2.10 Relative transcript quantification 
Gene expression was quantified by Quantifast SYBR Green qRT-PCR kit 
(Qiagen; 204054) with cDNA derived from ISE6 cells and qRT-PCR primers (Table 
3). This was used to quantify relative expression of genes of interest following 
dsRNA-mediated transcript knockdown. Additionally, qRT-PCR primers targeting 
the negative strand of the LGTV intermediate genome were used as in Mitzel et al 
[39] to identify relative LGTV genome expression. The real-time Applied 
Biosystems 7300 PCR system (Life Technologies) with MicroAmp Optical 96 well 
reaction plate with labeled barcode (Life Technologies; 4306737) was used with 
7300 system SDS RQ study software (v 1.4.1) to collect raw Ct cycle values. The 
ΔΔCt method was used to determine transcript expression relative to I. scapularis 
β-actin for the confirmation of transcript knockdown of genes of interest. Also,  
transcript expression relative to I. scapularis β-tubulin was used for determining 
effect on LGTV negative strand genome replication levels following transcript 
knockdown of genes of interest [39].  
4.2.11 DAVID functional clustering analyses 
 To identify biological function clusters of ISE6 proteins with KEGG orthology 
and mapped to I. scapularis KEGG pathways that exhibitied increased expression 
following LGTV infection and UV-LGTV treatment [87],  Genebank accession IDs 
were submitted for search in the Function Annotation Tool of DAVID 
(http://david.abcc.ncifcrf.gov/summary). All Gene Ontology options in the DAVID 
[147] clustering settings were selected for output. Significant clustering of functions 




enrichment score (≥1.3 is equal to a p value ≤0.05). Additionally, within each 
cluster, a modified Fisher Exact p value (p value ≤0.05 is ideal) was given for each 
function term with corresponding uploaded accession IDs.  
4.2.12 Analysis of predicted protein-chemical interactions using STITCH 
 The software STITCH (http://stitch.embl.de; [148]) was used to identify 
predicted I. scapularis protein-chemical interactions with compounds (TSA, OligoA, 
NAM, FAMO, Hexa, EGC, and ECG) screened in ISE6 cells. Compound 
name/abbreviation was uploaded and actions view was used with a prediction 
threshold search at >0.500 confidence showing no more than 50 interactants. 
4.2.13 Statistical analyses 
 Unpaired t-test statistical analyses were completed as described in Chapter 
2, Section 2.2.6.  
4.3 RESULTS 
4.3.1 Small molecule compound assays identify energy processes and histone 
acetylation associated with LGTV infection  
Trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor and 
acetylation activator of enzymes involved in intermediate metabolism, including 
MDH2, decreased viability of Vero cells (with and without LGTV infection) and 
LGTV replication (measured by infectious virus release pfu) directly with higher 
concentrations. Conversely, an increase in TSA concentrations directly increased 
ISE6 cell viability (with LGTV infection) and increased (~0.5 log pfu) LGTV 
replication (Fig 1 and 2A).  
The differential proteomic analysis from Chapter 3 identified candidate 




core histone H2A/H2B/H3/H4 (ISCW002300-PA). The LFQ quantitative proteomic 
analysis from Chapter 3 identified candidate histone deacetylase 1, 2, 3 
(ISCW007830-PA), histone H4 (ISCW019498-PA), histone (ISCW012234-PA), 
histone H2B (ISCW019496-PA), histone H1 (ISCW016230-PA), histone H2A 
(ISCW019497-PA and ISCW004478-PA), and histone H3 (ISCW003178-PA and 
ISCW002300-PA). STITCH predicted TSA to bind to candidate histone 
deacetylases (ISCW014481-PA, ISCW007923-PA, ISCW008957-PA, 
ISCW012528-PA, and ISCW007830-PA), bind and inhibit candidate deacetylases 
(ISCW014481-PA and ISCW008957-PA), and activate candidate histones 
(ISCW019498-PA and ISCW002300-PA) or candidate histone-modifying proteins 
(ISCW019432-PA and ISCW007938-PA) (Fig 3).  
In an attempt to inhibit the deacetylase activity of sirtuins (proteins that 
regulate biological pathways via deacetylase, demyristoylase, demalonylase, 
depalmitoylase, and desuccinylase activity) nicotinamide (NAM) was used and 
shown to reduce LGTV replication at high concentration (105 µM) in both Vero and 
ISE6 cells (Fig 4). At lower concentrations (≤102 µM), LGTV replication levels 
increased in Vero cells (only 102 µM concentration shown) following NAM 
treatment, this observation was not seen in ISE6 cells. The differential proteomic 
analysis from Chapter 3 identified candidate sirtuin type (ISCW023257-PA) and 
candidate poly [ADP-ribose] polymerase (ISCW019519-PA). The LFQ quantitative 
proteomic analysis from Chapter 3 identified only candidate poly [ADP-ribose] 
polymerase (ISCW019519-PA). STITCH predicted that NAM binds to and inhibits 




and candidate poly [ADP-ribose] polymerases (ISCW019519-PA and 
ISCW017128-PA) (Fig 5).  
Oligomycin A (OligoA), a mitochondrial H+ ATPase pump inhibitor, inhibits 
the end process of the electron transport chain by reducing ATP production. 
Increasing concentrations of OligoA resulted in a significant decrease in the 
viability of both Vero cells (~20%) and ISE6 cells (~60%) in the absence of LGTV. 
We observed a significant reduction (~1.5 log reduction in pfu in Vero cells and ~2 
log reduction in pfu in ISE6 cells) in LGTV in both mammalian and invertebrate 
systems with increasing concentration of OligoA (Fig 1 and 2B). The differential 
proteomic analysis from Chapter 3 identified candidate ATP synthase D chain 
(ISCW016217-PA) of the mitochondria ATPase pump. The LFQ quantitative 
proteomic analysis from Chapter 3 also identified candidate ATP synthase D chain 
(ISCW016217-PA). STITCH predicted that OligoA inhibits the candidate ATP 
synthase D chain (ISCW016217-PA) of the H+ ATPase pump in the mitochondria, 
and activates candidate serine/threonine protein kinase (ISCW020637-PA). 
In an effort to perturb the ISE6 glutaminolysis process, compounds were 
selected and tested in an assay to disrupt glutamate dehydrogenase, the key 
enzyme involved in creating α-ketoglutarate from glutamate (Fig 6), to evaluate the 
effect on LGTV infection. The following small molecules were used in functional 
compound assays: Famotidine (Famo), Hexachlorophene (Hexa), 
epigallocatechin (EGC), and epicatechin-3-gallate (ECG). A high concentration of 
Famo (105 µM) reduced LGTV replication in Vero (data not shown) and ISE6 cells. 




µM concentration did not affect cell viability) in ISE6 cells (Fig 7A and 7B). The 
differential proteomic analysis from Chapter 3 identified candidate glutamate 
dehydrogenase (ISCW000393-PA). The LFQ quantitative proteomic analysis from 
Chapter 3 also identified candidate glutamate dehydrogenase (ISCW000393-PA). 
STITCH predicted that Hexa binds and inhibits candidate glutamate 
dehydrogenase (ISCW000393-PA) and binds candidate mitogen-activated protein 
kinase (ISCW021966-PA).  
Tea polyphenols EGC and ECG reduce LGTV replication with higher 
concentrations (103 - 104 µM) and lower concentrations (10-1 - 104 µM) in ISE6 cells, 
respectively (Fig 8A and 8B). EGC has a higher IC50 (>50 µM) than ECG (>1.7 µM) 
[149-151]. Hexa and tea polyphenols (EGC, ECG, etc) have been found to be 
allosteric regulators of GDH. The differential proteomic analysis from Chapter 3 
identified candidate glutamate dehydrogenase (ISCW000393-PA). The LFQ 
quantitative proteomic analysis from Chapter 3 also identified candidate glutamate 
dehydrogenase (ISCW000393-PA). STITCH predicted that ECG binds candidate 
glutamate dehydrogenase (ISCW000393-PA) and activates candidate cAMP-
dependent protein kinase catalytic subunit (ISCW018284-PA).  
4.3.2 RNA interference transcript knockdown 
4.3.2.1 Identifying and characterizing genes of interest for RNAi-mediated 
transcript knockdown 
Criteria for choosing genes of interest from hundreds of ISE6 proteins (486 
ISE6 proteins from the differential proteomic screen of Chapter 3 and from 
Grabowski et al [87]) were derived from protein expression change following LGTV 




or not orthologous based on the KEGG analysis), and stronger protein 
identification (proteins identified with ≥2 peptides). Fig 9 shows the process taken 
to derive ten genes of interest: FAH (Fumar), ERP29, ALDH4A1 (DPCD), VNN 
(CNHydro), MDH2, PARP, CMPK1 (CUKinase), ACAT1, hypothetical protein 
(Hypo195), and hypothetical protein (Hypo576).  
First, ISE6 proteins that showed increased expression and with ≥ 2 peptides 
were selected. Next, the remaining proteins were separated into orthologous and 
non-orthologous proteins (orthologous refers to KEGG Orthology). Orthologous 
proteins with putative GO function, InterPro protein domain function, and overlap 
protein identifications with other flavivirus-host proteomic studies [56, 65, 109, 110] 
were then separated. Non-orthologous proteins were separated based on putative 
GO function and InterPro protein domain function, which was also used to identify 
proteins with no known orthology and orphan proteins.  
Cluster analyses provide insight into ISE6 cellular responses following 
LGTV infection and UV-LGTV treatment. ISE6 proteins mapped to I. scapularis 
KEGG pathways showing increased expression following only LGTV infection, 
both LGTV infection and UV-LGTV treatment, and only UV-LGTV treatment [87] 
were used to identify clusters of processes derived from GO descriptions from 
DAVID. Ribonucleoprotein/ribosomal/translation/protein metabolic functions and 
genetic/transcriptional control were the primary functions occurring with LGTV 
infection and UV-LGTV treatment (45 proteins searched, DAVID used 33 for 




be involved in the ribonucleoprotein/ribosomal/translation/protein metabolic 
function. 
Functional cluster analyses revealed enriched translation, ribosomal 
function, and protein metabolic processing (13 proteins searched, DAVID used 8 
for clustering) following LGTV infection (Fig 10B). Results revealed enriched 
protein transport, cytoplasmic ribonucleoprotein control, along with spliceosome 
function (20 proteins searched, DAVID used 16 for clustering) following UV-LGTV 
treatment. Results revealed enriched functions of nitrogen metabolic processing 
as well as amine/amino acid metabolic processing (12 proteins searched, DAVID 
used 9 for clustering) following both LGTV infection and UV-LGTV treatment. Of 
the eight ISE6 proteins selected, MDH2 and PARP were found in the enrichment 
of translation, ribosomal function, and protein metabolic processing functions. 
CUKinase, DPCD, and Fumar were all found in the enrichment of nitrogen 
metabolic processing and amine/amino acid metabolic processing. ACAT1 only 
clustered in nitrogen metabolic processing function. 
Four of the eight proteins have <50% amino acid conservation with the 
human ortholog (Table 4). Additionally, the most common function that the 
orthologous proteins mapped in was amino acid metabolism. Six of the eight 
proteins were involved in metabolic response(s). Upon sequencing cDNA 
amplified from the transcripts for the selected ten genes of interest of the female I. 
scapularis tick and I. scapularis ISE6 cell line, 96 % and greater conservation was 
seen from all genes of interest when compared to IscaW1 annotation gene models 




compared to the female tick, where four genes of interest had decreased sequence 
similarity in the female tick compared to ISE6 cells. CUKinase, Hypo195, and 
Hypo576 had 2 or less nucleotide mismatches between female tick and/or ISE6 
cell line, revealing them to be the three out of ten genes of interest with the least 
amount of nucleotide change.  
4.3.2.2 Confirmation of dsRNA-mediated, transcript knockdown of genes of 
interest 
High dsRNA concentrations was detrimental to tick cell viability. Using 
dsRNA derived from exogenous pGEM, higher concentrations of 100 and 50 ng 
revealed detrimental effects on ISE6 cell viability, while lower concentrations of 25 
and 10 ng dsRNA showed no effect or an increase in ISE6 cell viability (Fig 11).  
 We observed no significant effect on cell viability of RNAi treated cells (Fig 
12). In parallel with cell viability readings, transcript knockdown of all genes of 
interest was confirmed through qRT-PCR (Fig 13). The 10 ng dsRNA transfections 
was used for transcript knockdown of the genes of interest. 
4.3.2.3 Transcript knockdown effect of genes of interest on LGTV infection 
 No significant effect on ISE6 cell viability occurred with transcript 
knockdown of genes of interest and LGTV infection (Fig 14). Three genes of 
interest (CNHydro, ACAT1, and Hypo576) revealed decreased LGTV negative 
strand genome levels compared to the negative pGEM control (Fig 15). Transcript 
knockdown of all genes of interest revealed a statistically-significant decrease in 
LGTV replication levels compared to negative pGEM control when measuring 
LGTV replication in pre knockdown ISE6 cells (Fig 16). In addition, transcript 




revealed a statistically-significant decrease in LGTV replication levels compared 
to the negative pGEM control when measuring LGTV replication during transcript 
knockdown of genes of interest in ISE6 cells (Fig 17). Effects on LGTV infection 
can be found in Table 6.  
Localization of ortholog proteins were predicted as shown in Fig 18. DPCD, 
MDH2, and ACAT1 are all predicted to be in the mitochondria. Fumar and 
CUKinase are likely found in the cytosol. PARP and CUKinase are predicted to be 
found in the nucleus. ERP29 likely maintains a presence in the endoplasmic 
reticulum as a secreted protein. CNHydro is likely found in the plasma membrane. 
Since no information is known on Hypo195 and Hypo576, the known locations of 
these proteins is currently unknown however Hypo576 is suggested to be localized 
in the cytoplasm since the transcript knockdown of this gene affected LGTV 
negative strand genome replication. 
4.4 DISCUSSION 
4.4.1 Impact of LGTV infection on signaling in ISE6 cells 
Several proteins identified from Chapter 3 were suggested to impact cellular 
signaling mechanisms associated with LGTV infection [87]. The candidate histone 
deacetylase 1,2,3 (ISCW007830-PA) exhibited decreased expression following 
both LGTV infection and UV-LGTV treatment. Histone acetylation can impact viral 
replication and virus infection can manipulate histones in order to control host 
transcriptional regulation [111, 112]. Viral proteins are capable of binding 
deacetylase enzymes [112] and other host proteins associated with acetylation 




co-repressor in the notch signaling pathway. It was hypothesized that LGTV 
infection may be altering this histone deacetylase to better control host gene 
regulation.  Treatment of LGTV-infected ISE6 cells with TSA increased LGTV 
replication, suggesting that LGTV infection impacts gene regulation through 
histone deacetylase and associated notch signaling pathway. The candidate 40S 
ribosomal protein S6 (ISCW024315-PA) and Mo25 protein (ISCW004710-PA) 
exhibited increased expression in LGTV-infected cells. These proteins may be 
members of the mTOR signaling pathway (http://www.genome.jp/kegg-
bin/show_pathway?map04150). The mTOR signaling pathway has been 
implicated in Human cytomegalovirus (HCMV) infection in mammalian cells [113, 
114] and DENV infection in A. aegypti mosquitoes [115]. Increased expression of 
Mo25 may reflect a stress response and increased expression of S6 may reflect 
an increase in translation to maintain growth of the infected cell or facilitate LGTV 
replication. Manipulation of mTOR signaling has been noted with WNV infection in 
mammalian systems [116] as well. The candidate calcyclin-binding protein 
CacyBP (ISCW013691-PA) had increased expression in UV-LGTV- treated cells 
and decreased expression in LGTV-infected cells. In other systems, CacyBP 
orthologs function in the Wnt signaling pathway. Our observation suggested an 
increase in proteolysis following virus treatment since the Wnt pathway is 
associated with the Ca2+-dependent, ubiquitin-mediated proteolysis pathway. 
Future investigations regarding roles of post-translational modifications in 
regulating signaling pathways following tick-borne flavivirus infection would be a 




4.4.2 Identification of selected proteins associated with LGTV replication 
TSA was predicted to bind to candidate histone deacetylase 1, 2, 3 
(ISCW007830-PA), activates candidate histone H4 (ISCW19498-PA), and 
activates candidate core histone H2A/H2B/H3/H4 (ISCW002300-PA). From these 
predictions, it can be further hypothesized that TSA may increase tick histone 
acetylation. This suggested that an increased amount of DNA for transcription was 
produced by the cell following LGTV infection. Although metabolic enzymes have 
also shown increased acetylation levels with TSA [153] in mammalian systems, 
STITCH chemical-protein analyses with TSA did not predict any tick metabolic 
enzymes interacting. Overall, TSA increases lysine acetylation (histones and 
metabolic enzymes) and increases LGTV infection in ISE6 cells although exact 
confirmation of acetylated peptides with TSA treatment was not completed. This 
suggested but did not prove that an increase in lysine acetylation of ISE6 histones 
increases LGTV infection. Further targeted experiments focusing on the 
mechanism of histone lysine acetylation and LGTV infection will need to be 
completed. 
NAM has been known to inhibit sirtuins (although NAM was predicted to 
inhibit poly [ADP-ribose] polymerase, most likely through feedback inhibition), 
which perform deacetylation activity in the cell. The higher concentrations 
screened in Vero and ISE6 cells may have saturated the effect on the cell, hence 
why lower concentrations of the compound may have shown an increased LGTV 




of NAM in ISE6 cells needs to be performed before conclusions can be made on 
the biological effects from the compound on LGTV replication in the tick system. 
Our in vitro studies have shown that the compounds TSA and OligoA can 
affect levels of LGTV replication, presumably through impact on a variety of 
metabolic processes. TSA is thought to inhibit histone deacetylases and stimulate 
the acetylation of metabolic enzymes [153], while OligoA may inhibit oxidative 
phosphorylation and electron transport. TSA is known to create effects on 
transcription and translation that may subsequently impact metabolic pathways. 
OligoA may activate AMPK activity [154], inhibit ATP production, and affect energy 
levels. Thus, further studies may be required to determine the mode of action of 
TSA and OligoA in the LGTV-ISE6 system. 
Glutaminolysis is a process that produces an alternative energy source that 
converts glutamine into the production of ATP. Increased expression of proteins 
associated with glutaminolysis (Fig 6) suggest that LGTV infection in ISE6 cells 
may stimulate glutaminolysis that converts glutamate to α-ketoglutarate, which is 
a key intermediate in the TCA cycle. Studies suggest that glutaminolysis is 
manipulated by viruses during infection of human cells by both HCMV [129, 130] 
and HCV infection [56]. These studies suggest that glutaminolysis/glutamate 
metabolic enzymes and α-ketoglutarate are critical for maintaining the TCA cycle, 
supporting oxidative phosphorylation, and ATP production in the infected cell. 
Additionally, stimulation of α-ketoglutarate has been shown to increase mTOR 
activity [131, 132], which works in parallel with glutaminolysis. Small molecule 




activity with the goal of inhibiting activities of glutamate metabolic enzymes during 
flavivirus infection. We hypothesized that Hexa disrupted glutamate metabolism 
and/or glutaminolysis and decreased LGTV replication. However, assessment of 
downstream metabolites from glutamate metabolism (glutamate levels) and 
glutaminolysis (α-ketoglutarate levels) following these compound treatments to 
cells needs to be completed in order confirm that these processes are being 
affected. 
4.4.3 Silencing of metabolic and protein processing functions decrease LGTV 
infection 
4.4.3.1 Optimization of RNA interference conditions and response in LGTV 
infection 
 Transcript knockdown was shown not to cause detrimental effects to ISE6 
cells before attempting to measure transcript knockdown effect on LGTV infection. 
Figs 12 and 14 suggest that the ISE6 cell viability was not significantly affected by 
transcript knockdown of genes of interest using the optimized 10 ng dsRNA. The 
10 ng dsRNA concentration was sufficient for knocking down the ten genes of 
interest. 
 By comparing the effect of transcript knockdown of genes of interest to the 
LGTV 3UTR positive control on the LGTV negative strand genome replication, 
potential steps of the LGTV life cycle being affected may be suggested. It was 
predicted that LGTV replication levels would be within the range of the negative 
pGEM and positive LGTV 3UTR controls. In combination with the effects of 
transcript knockdown on LGTV negative strand genome replication, effect on 





4.4.3.2 I. scapularis metabolic and protein processing enzymes necessary for 
LGTV infection 
 Fig 19 shows the possible mechanisms by which seven I. scapularis genes 
of interest (ERP29, DPCD, CNHydro, MDH2, ACAT1, Hypo195, and Hypo576) 
may affect LGTV replication. Transcript knockdown for two genes of interest with 
orthology (CNHydro and ACAT1) and one gene of interest with no known function 
resulted in reduction of both LGTV genome replication and LGTV replication.  
CNHydro is involved in cofactors/vitamins and pantothenate/CoA 
biosynthesis metabolism and location on the plasma membrane that can serve as 
a GPI-anchored protein suggest deficiency in formation of the replication complex, 
genome replication, LGTV attachment, endocytosis, release of genome into the 
cytoplasm.  
ACAT1 is involved in carbohydrate, lipid, amino acid, and 
terpenoids/polykeytides metabolism. The identification of a lipid (fatty acid) 
metabolism pathway (from KEGG) suggested that ACAT1 may affect the formation 
of replication complexes, which require lipids for membrane formation. Also 
involved in carbohydrate (pyruvate) metabolism, ACAT1 may affect replication 
complex formation through reducing necessary energy processes. The ACAT1 
ortholog was identified in an HCV-HUH7.5 cell proteomic study [56], but no 
expression change was observed with HCV infection.  
The role of Hypo576 was also unknown. It was also suggested to affect 
LGTV attachment, endocytosis, virus fusion/release of genome, the formation of 




 RNAi-induced, transcript knockdown of genes of interest that led to no 
change in LGTV negative strand genome levels compared to the negative pGEM 
control may have similar effect on LGTV attachment, endocytosis, virus 
fusion/release of genome, formation of replication complexes/vacuoles, or 
formation of dsRNA intermediate genome with the negative control. Transcript 
knockdown of three genes of interest with orthology (ERP29, DPCD, and MDH2) 
and one gene of interest with unknown function (Hypo195) resulted only in a 
reduction in LGTV replication. 
ERP29 is involved in protein folding/sorting/degradation and its effect on 
virus infection associated with transcript knockdown suggested deficiency in virion 
assembly, virion egress, prM cleavage, and/or virus budding. The ERP29 ortholog 
was identified in an HCV-HUH7.5 cell proteomic study [56], but no expression 
change was observed with HCV infection. ERP29, an established stress response 
protein, has been found with increased expression in mouse brain tissue following 
Japanese Encephalitis virus (flavivirus) infection [155]. In polyomavirus infection, 
ERP29 was identified to unfold viral proteins [156-158] to aid in subsequent virus 
binding and release from the ER lumen, which implicates ERP29 does have the 
ability to aid in virus infection. Although involved in stress response, it is unknown 
whether ERP29 is directly aiding in flavivirus infection.  
DPCD amino acid metabolic involvement may affect the viral protein 
translation. Additionally, involvement in glutamate metabolism (predicted to 
influence glutaminolysis) has an effect on energy homeostasis, which may lead to 




conversion of delta-1-pyrroline-5-carboxylate (P5C), which is derived either from 
proline or ornithine, to glutamate. This is a necessary step in the pathway 
interconnecting the urea and tricarboxylic acid cycles with glutaminolysis. In 
addition, DPCD was identified with increased protein expression [56] and gene 
expression [159] following HCV infection. It is unknown whether the increased 
expression of DPCD aids flavivirus infection or whether it is the cell response to 
stress and/or to maintain energy levels.  
MDH2 carbohydrate metabolic involvement may affect the translation 
and/or formation of viral proteins. A key rate-limiting enzyme in the citrate cycle 
and in pyruvate metabolism may suggest that MDH2 can control energy 
homeostasis levels and in parallel, affecting cellular but also viral protein 
production that requires ATP. Increased protein expression of MDH2 has been 
identified following HCV infection [56]. Increased transcript expression of MDH2 
has been identified with bloodfed salivary gland tissue of I. scapularis nymphs [72]. 
In addition, MDH2 protein expression has been identified within I. scapularis 
synganglia tissue [91]. It is unknown whether the increased expression of MDH2 
aids flavivirus infection or whether it is the cell response to stress and/or to maintain 
energy levels.  
The role of Hypo195 is currently unknown. It was suggested to affect LGTV 
viral protein translation, virion assembly, virion egress, prM cleavage, and/or virus 
budding. In addition, Hypo195 protein expression has been identified within I. 




 Overall, a transcript knockdown of genes of interest that lead to decreased 
LGTV negative strand genome levels and a decreased infectious LGTV release 
(CNHydro, ACAT1, and Hypo576) reveal that LGTV genome replication may be 
affected by reduction in viral protein translation, genome replication complexes, or 
synthesis of dsRNA genome intermediate. Infectious LGTV release was reduced 
in pre knockdown cells and in cells where transcript knockdown of genes of interest 
was completed during LGTV infection with seven genes of interest (ERP29, DPCD, 
CNHydro, MDH2, ACAT1, Hypo195, and Hypo576). This provided confidence that 
the transcript knockdown of these genes can reduce TBF infection before and 
during infection. This study was the first report of CNHydro, Hypo195, and 
Hypo576 with increased expression following flavivirus infection. Also, this was the 
first report of DPCD, CNHydro, MDH2, ACAT1, Hypo195, and Hypo576 transcript 
knockdown and effect on flavivirus infection.  
Three genes of interest (Fumar, PARP, and CUKinase) did not reduce 
LGTV replication when transfection was completed during LGTV infection in ISE6 
cells, thus were not considered to be involved with LGTV infection. Transcript 
knockdown of ISE6 amino acid/vitamin/cofactor/carbohydrate/lipid metabolic 
enzymes (DPCD, CNHydro, MDH2, and ACAT1) and a folding/sorting/degradation 
protein (ERP29) were correlated with a decrease in LGTV replication. This 
observation suggested that efficient LGTV replication (denoted as the negative 
pGEM control) either directly or indirectly involved these these genes of interest. 




enzymes and folding/sorting/degradation proteins with increased expression 
following LGTV infection were involved in LGTV infection was accepted. 
4.4.3.3 Candidate proteins for future therapeutic development 
Approaches to limit transmission of tick-borne pathogens may target either 
the tick vector or the mammalian reservoir. Small molecule compounds may have 
application for domestic/companion animals and humans, and, potentially provide 
the opportunity to reduce pathogen circulation in natural reservoirs. Vaccines could 
reduce pathogen circulation in domestic/companion animals, humans, and in 
natural reservoirs. Antigens developed to a pathogen protein have been used for 
vaccine development targeting the natural reservoir [160, 161], and this may be 
possible with arthropod vector proteins as well. Currently, oral bait formulations 
including vaccines targeting pathogen/tick proteins is one way to reduce pathogen 
circulation and reduce transmission.  
de la Fuente and Merino (2013) suggest that RNAi functional analysis of 
tick proteins associated with pathogen infection are necessary before development 
of protein vaccines [162]. If successful, vaccines could be developed and vaccine 
conducted in clinic [163] and field [161, 164] may be completed. This project 
provides the next step to functionally characterize a candidate protein for 








4.5 FIGURES, TABLES, AND LEGENDS 
Table 1. PCR primers for selected genes of interest. Abbreviated names for 
genes of interest, housekeeping gene (β-actin), and RNAi controls (pGEM and 
LGTV 3UTR) include Fumar = fumarylacetoacetase; ERP29 = endoplasmic 
reticulum protein 29; DPCD = 1-pyrroline-5-carboxylate dehydrogenase (aldehyde 
dehydrogenase 4A1); CNHydro = pantetheine hydrolase (vanin); MDH2 = malate 
dehydrogenase; PARP = poly [ADP-ribose] polymerase; CUKinase = UMP-CMP 
kinase; ACAT1 = acetyl-CoA acetyltransferase; Hypo195 = hypothetical protein; 
Hypo576 = hypothetical protein; β-actin = beta-actin; pGEM = pGEM plasmid 
cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of genome. 
Primer Name Primer Sequence 
F Fumar (ISCW020196) 5’-GGTTCCAATGTCCCAGGCTA-3’ 
R Fumar (ISCW020196) 5’-CCTTGTGAAGGAGGTAGGGC-3’ 
F ERP29 (ISCW018425) 5’-CGAAGTTCAAAGTGACGCTGG-3’ 
R ERP29 (ISCW018425) 5’-CTGGTGATCTTTCCGTTGCG-3’ 
F DPCD (ISCW015982) 5’-TCAGCCCATCACAACAGACC-3’ 
R DPCD (ISCW015982) 5’-TTGTCCGGCACGTAGACAC-3’ 
F CNHydro (ISCW004822) 5’-TACCACGGTGACGAGATTGC-3’ 
R CNHydro (ISCW004822) 5’-TATGTGAGCTCCGCTTGAGG-3’ 
F MDH2 (ISCW003528) 5’-CTGCGGACAAATCGCCAAAG-3’ 
R MDH2 (ISCW003528) 5’-TGAAGCCCTTGACTTGAGGC-3’ 
F PARP (ISCW019519) 5’-GCAAGGATCTTCCGCTGGAT-3’ 
R PARP (ISCW019519) 5’-CGAAGACTCACGTCTCCACC-3’ 
F CUKinase (ISCW012446) 5’-TACAAGCACCTGTCGGCG-3’ 
R CUKinase (ISCW012446) 5’-TGAGGCTCTCCATGTTGTCG-3’ 
F ACAT1 (ISCW016117) 5’-CGTCTACGATGGCCTGACTG-3’ 
R ACAT1 (ISCW016117) 5’-TTCGAGCAATGGGCTTCACT-3’ 
F Hypo195 (ISCW011195) 5’-CAACAAACTCGGCGGCTTC-3’ 
R Hypo195 (ISCW011195) 5’-GCACCCTTCAGGAAGTTGCTC-3’ 
F Hypo576 (ISCW020576) 5’-GGAGCCCAACTGCATCTACC-3’ 
R Hypo576 (ISCW020576) 5’-TGAGCCTTGATGCGGTCTAC-3’ 
F β-actin (ISCW024111)∞ 5’-GCCGGGACCTTACAGACTATC-3’ 
R β-actin (ISCW024111)∞ 5’-CACGGACAATTTCACGCTCG-3’ 
F pGEM 5’-GGTATCAGCTCACTCAAAGG-3’ 
R pGEM 5’-GAACGACCTACACCGAACT-3’ 
F LGTV 3UTR (EU790644.1)+ 5’-GCCAGACACAAGGAGTCCAA-3’ 
R LGTV 3UTR (EU790644.1)+ 5’-GATGGTGGCTCAGGGAGAAC-3’ 
*F denotes forward primer 
*R denotes reverse primer 
*ISCW- - - - - - denotes VectorBase accession ID 
∞Derived from [39] 





Table 2. T7-tagged primers for selected genes of interest. Abbreviated names 
for genes of interest and RNAi controls (pGEM and LGTV 3UTR) include Fumar = 
fumarylacetoacetase; ERP29 = endoplasmic reticulum protein 29; DPCD = 1-
pyrroline-5-carboxylate dehydrogenase (aldehyde dehydrogenase 4A1); CNHydro 
= pantetheine hydrolase (vanin); MDH2 = malate dehydrogenase; PARP = poly 
[ADP-ribose] polymerase; CUKinase = UMP-CMP kinase; ACAT1 = acetyl-CoA 
acetyltransferase; Hypo195 = hypothetical protein; Hypo576 = hypothetical protein; 
pGEM = pGEM plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’ 
untranslated region of genome. 
































































F T7-pGEM 5’-TAATACGACTCACTATAGGGGGTATCAGCTCACTCAAAGG-3’ 
R T7-pGEM 5’-TAATACGACTCACTATAGGGGAACGACCTACACCGAACT-3’ 
F T7-LGTV 3UTR 
(EU790644.1)+ 
5’-TAATACGACTCACTATAGGGCCAGACACAAGGAGTCCAA-3’ 
R T7-LGTV 3UTR 
(EU790644.1)+ 
5’-TAATACGACTCACTATAGGGATGGTGGCTCAGGGAGAAC-3’ 
*F denotes forward primer 
*R denotes reverse primer 
*ISCW- - - - - - denotes VectorBase accession ID 




















Table 3. qRT-PCR primers for selected genes of interest. Abbreviated names 
for genes of interest, housekeeping genes (β-actin and β-tubulin), and LGTV 
negative strand primers include Fumar = fumarylacetoacetase; ERP29 = 
endoplasmic reticulum protein 29; DPCD = 1-pyrroline-5-carboxylate 
dehydrogenase (aldehyde dehydrogenase 4A1); CNHydro = pantetheine 
hydrolase (vanin); MDH2 = malate dehydrogenase; PARP = poly [ADP-ribose] 
polymerase; CUKinase = UMP-CMP kinase; ACAT1 = acetyl-CoA 
acetyltransferase; Hypo195 = hypothetical protein; Hypo576 = hypothetical protein; 
β-actin = beta-actin; β-tubulin = beta-tubulin; LGTV negative strand = LGTV strain 
TP21 negative strand. 
Primer Name Primer Sequence 
F Fumar (ISCW020196) TCACGTTCGAGAATCTGCCG 
R Fumar (ISCW020196) GTAGTCTCCTATGGCCACGC 
F ERP29 (ISCW018425) TCAAAGCGGTCTCACGCTAC 
R ERP29 (ISCW018425) GTACGCTGCCCTTTGTGGTG 
F DPCD (ISCW015982) TTGGAGGCAAGGAGATCAGG 
R DPCD (ISCW015982) CAGGCTGGTGTTTATCGCCT 
F CNHydro (ISCW004822) CTACAACACCAACGTGGCCT 
R CNHydro (ISCW004822) AAGGGCTCCACAAACAGGTG 
F MDH2 (ISCW003528) GGTGTTCAAGAAGCGGGGT 
R MDH2 (ISCW003528) ACGTTCACTGTGGCTGGGTC 
F PARP (ISCW019519) CTCGACGGAGTATGCCAAGT 
R PARP (ISCW019519) CATCTTGGAGAAGGCCCCAT 
F CUKinase (ISCW012446) GGCCTCTTGACCATGTCTGG 
R CUKinase (ISCW012446) AATCTTCTGACACTGGGTGCC 
F ACAT1 (ISCW016117) CAGGAGTTCTTTGGCTGCTG 
R ACAT1 (ISCW016117) TGAACACCTCCTGGACATCG 
F Hypo195 (ISCW011195) CACCTCGACAAACTGAGCAC 
R Hypo195 (ISCW011195) CGTCCGTGCATAACTGGCAA 
F Hypo576 (ISCW020576) TGGCTGAACACGGACATCAAG 
R Hypo576 (ISCW020576) TCGGGCTCAACAGGGGAC 
F β-actin (ISCW024111)∞ GCCGGGACCTTACAGACTATC 
R β-actin (ISCW024111)∞ CACGGACAATTTCACGCTCG 
F β-tubulin (ISCW005137) ACCTTCATTGGCAACAGCAC 
R β-tubulin (ISCW005137) CCCTCTCCGGTGTACCAGT 
F LGTV negative strand (EU790644.1)+∞ GTCTCCGGTTGCAGGACTGT 
R LGTV negative strand (EU790644.1)+∞ CTCGGTCAGTAGGATGGTGTTG 
*qRT-PCR consisted of cDNA synthesis of I. scapularis ISE6 RNA first, then 
conducting qPCR second with cDNA 
*F denotes forward primer 
*R denotes reverse primer 
*ISCW- - - - - - denotes VectorBase accession ID 
∞Derived from [39] 





Fig 1. Predicted effect of Trichostatin A and Oligomycin A in ISE6 cells. 
Trichostatin A activation of histones and MDH2; Oligomycin A inhibition of H+ ATP 
synthase pump of the mitochondria. Red denotes TCA Cycle, MDH2 enzyme with 
increased expression following LGTV infection. Blue denotes TCA Cycle, CS and 







Fig 2. In vitro ISE6 assay showing effects of (A) trichostatin A and (B) 
oligomycin A on cell viability and LGTV replication. Release of LGTV was 
assessed by viral titer (pfu/ml) using plaque assays in BHK cells. Cell viability was 
determined with alamarBlue reagent and fluorescent assay and percentage was 








Fig 3. Predicted interactions of trichostatin A on I. scapularis proteins. 
Predictions were completed with STITCH (stitch.embl.de). Circles denote tick 
proteins with VectorBase accession IDs. Green arrow: denotes TSA activation of 
tick protein. Red line: denotes TSA inhibition of tick protein. Blue line: denotes 
binding activity. 
  












Fig 4. In vitro ISE6 assay showing effects of nicotinamide on cell viability 
and LGTV replication. Release of LGTV was assessed by viral titer (pfu/ml) using 
plaque assays in BHK cells. Cell viability was determined with alamarBlue reagent 
and fluorescent assay and percentage was normalized against solvent only control 
in both LGTV-infected and mock- treated ISE6/Vero cells. 






Fig 5. Predicted interactions of nicotinamide on I. scapularis proteins. 
Predictions were completed with STITCH (stitch.embl.de). Circles denote tick 
proteins with VectorBase accession IDs. Green arrow: denotes nicotinamide 
(vitamin B) activation of tick protein. Red line: denotes nicotinamide inhibition of 












Fig 6. ISE6 proteins associated with glutaminolysis. ISE6 glutaminolysis and 
mTOR signaling proteins altered with LGTV infection are shown.  GDH denotes 








Fig 7. In vitro ISE6 assay showing effects of (A) famotidine and (B) 
hexachlorophene on cell viability and LGTV replication. Release of LGTV was 
assessed by viral titer (pfu/ml) using plaque assays in BHK cells. Cell viability was 
determined with alamarBlue reagent and fluorescent assay and percentage was 

















Fig 8. In vitro ISE6 assay showing effects of (A) epigallocatechin and (B) 
epicatechin-3-gallate on cell viability and LGTV replication. Release of LGTV 
was assessed by viral titer (pfu/ml) using plaque assays in BHK cells. Cell viability 
was determined with alamarBlue reagent and fluorescent assay and percentage 
was normalized against solvent only control in both LGTV-infected and mock- 
treated ISE6/Vero cells. 















Fig 9. Selection of genes of interest from large-scale proteomics screen. ISE6 
proteins from the differential proteomic analysis at 36 hpi was searched. Using a 
combination of protein expression, protein orthology, number of peptides identified 
for each protein, pathways, and predicted functional analyses, a small percentage 
of proteins were selected for further downstream RNAi transcript knockdown 
analyses. ISE6 proteins with increased expression, with ≥2 peptides, were 
separated via presence/absence of KEGG orthology to where predicted, putative 
function was used (or not used; orphan proteins) to identify a subset of selected 
proteins. * denotes ortholog proteins that have been identified in other flavivirus-
host proteomic studies. Red denotes the followed filtering path to obtain the final 







Fig 10. DAVID enrichment/cluster analysis identifies significant functions of 
ISE6 proteins with increased expression following LGTV infection and UV-
LGTV treatment. ISE6 proteins with increased expression following LGTV 
infection and/or UV-LGTV treatment from the differential proteomic analysis at 36 
hpi was searched. Enrichment (E) score of ≥ 1.3 is equal to a ≤ 0.05 p value; higher 
the E number, stronger the enrichment of proteins to that particular cluster function. 
Proteins searched with all virus treatment (A) and proteins searched specific to 
virus-type treatment (B) are listed. Red denotes six of the eight selected proteins 













Table 4. Selected ISE6 proteins/genes of interest.  







Function Human (H. sapien) 








protein 29 (ERP29); K09586 





















polymerase (PARP); K10798 































































482/486 (99%); 4 0.0 500/506 (98%); 6 0.0 
ERP29 
553 
491/495 (99%); 4 0.0 466/470 (99%); 4 0.0 
DPCD 
534 










252/254 (99%); 2 e-134 249/255 (97%); 6 e-125 
PARP 310 241/250 (96%); 9 e-113 257/259 (99%); 2 e-135 
CUKinase 
349 
265/267 (99%); 2 e-142 249/250 (99%); 1 e-134 
ACAT1 
392 
240/244 (98%); 4 e-123 253/256 (98%); 3 e-133 
Hypo195 
300 
245/246 (99%); 1 e-129 244/246 (99%); 2 e-127 
Hypo576 
483 
424/425 (99%); 1 0.0 430/430 (100%); 
0 
0.0 
1coverage denotes genes of interest length of transcript sequenced to 
corresponding gene model sequence from the Wikel strain I. scapularis tick 
genome W1. 
2nucleotide mismatch compared to sequence of corresponding gene model from 
the Wikel strain I. scapularis tick genome W1. 
*Red denotes either the highest nucleotide mismatch between a gene of interest 
expressed in the tick versus in the tick cell line or the lowest expect value between 
a gene of interest expressed in the tick versus in the tick cell line. This reveals the 
degree of nucleotide change of each of the genes of interest between wildtype 
I.scapularis female tick and I.scapularis tick cells versus the I.scapularis Wikel 












Fig 11. Effect of transfection with various dsRNA concentrations on ISE6 cell 
viability. Xtreme (Xtr) transfection reagent was used to optimize dsRNA (pGEM 
control) concentrations in ISE6 cells transfected for 60 hours. Cell viability readings 
were compared with Xtreme + OptiMEM (Xtr + Opti; gray bar) control. Red boxes 
denote dsRNA concentrations that were not detrimental to ISE6 cell viability. RLU 
denotes relative light units (fluorescent measurement with 560 nm excitation and 
590 emission). Error bars represent standard error of the mean. Statistical 
unpaired t-test was completed between Xtr + Opti control and specific pGEM 
dsRNA concentration. Asterisks denote: *p value≤0.05 and **p value≤0.01. Three 
technical replicates for each treatment were performed within a biological replicate. 










Fig 12. Effect of transfection with dsRNA for genes of interest on ISE6 cell 
viability. Abbreviated names for genes of interest and RNAi controls (pGEM and 
LGTV 3UTR) include Fumar = fumarylacetoacetase (ISCW020196); ERP29 = 
endoplasmic reticulum protein 29 (ISCW018425); DPCD = 1-pyrroline-5-
carboxylate dehydrogenase (aldehyde dehydrogenase 4A1; ISCW015982); 
CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 = malate 
dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase 
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetyl-
CoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein 
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM 
plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of 
genome. Xtreme (Xtr) transfection reagent was used with 10 ng dsRNA (pGEM, 
LGTV 3UTR, and gene of interest specific) concentration in ISE6 cell transfections 
of 96 wells (~1x105 cells) for 60 hours. Cell viability readings were conducted at 12 
hours after the 60 hours post transfection. Cell viability readings were compared 
with the negative control pGEM dsRNA (light gray bar). LGTV 3UTR dsRNA is the 
positive control (dark gray bar) directed towards the LGTV genome that was used 
for detrimental effect on LGTV genome replication/replication. RLU denotes 
relative light units (fluorescent measurement with 560 nm excitation and 590 
emission). Error bars represent standard error of the mean. Statistical unpaired t-
test was completed between negative pGEM dsRNA control and specific I. 
scapularis dsRNA for gene of interest. Three technical replicates for each 
treatment were performed within a biological replicate. One biological replicate 





Fig 13. Transcript knockdown of I. scapularis genes of interest in ISE6 cells. 
Abbreviated names for genes of interest and RNAi controls (pGEM and LGTV 
3UTR) include Fumar = fumarylacetoacetase (ISCW020196); ERP29 = 
endoplasmic reticulum protein 29 (ISCW018425); DPCD = 1-pyrroline-5-
carboxylate dehydrogenase (aldehyde dehydrogenase 4A1; ISCW015982); 
CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 = malate 
dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase 
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetyl-
CoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein 
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM 
plasmid cloning vector. Relative expression was compared to I. scapularis β-actin 
gene in pGEM- and specific gene of interest-transfected cDNA. pGEM dsRNA-
transfected (gray bars) compared with I. scapularis-specific dsRNA-transfected 
(white bars) ISE6 cells (~1x105 cells). After 10 ng dsRNA transfection was 
completed, ISE6 total RNA was collected at 60 hours post transfection. Relative 
transcript expression was used to identify fold change (transcript expression of 
genes of interest were compared to transcript expression of β-tubulin) from ISE6 
cells. Error bars represent standard error of the mean. Statistical unpaired t-test 
was completed between negative pGEM dsRNA control and specific I. scapularis 
dsRNA for gene of interest. Asterisks denote: *p value≤0.05, **p value≤0.01, and 
***p value≤0.001. Three technical replicates for each treatment were performed 









Fig 14. Effect of transfection with dsRNA for genes of interest on LGTV-
infected ISE6 cell viability. Abbreviated names for genes of interest and RNAi 
controls (pGEM and LGTV 3UTR) include Fumar = fumarylacetoacetase 
(ISCW020196); ERP29 = endoplasmic reticulum protein 29 (ISCW018425); DPCD 
= 1-pyrroline-5-carboxylate dehydrogenase (aldehyde dehydrogenase 4A1; 
ISCW015982); CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 = 
malate dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase 
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetyl-
CoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein 
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM 
plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of 
genome. Xtreme (Xtr) transfection reagent was used with 10 ng dsRNA (pGEM, 
LGTV 3UTR, and gene of interest specific) concentration in ISE6 cell transfections 
of 96 wells (~1x105 cells) for 60 hours, then LGTV infection was completed with 
transfected cells. Cell viability readings were conducted from 12 hours post 
infection. Cell viability readings were compared with the negative control pGEM 
dsRNA (light gray bar). LGTV 3UTR dsRNA is the positive control (dark gray bar) 
directed towards the LGTV genome that was used for detrimental effect on LGTV 
genome replication/replication. RLU denotes relative light units (fluorescent 
measurement with 560 nm excitation and 590 emission). Error bars represent 
standard error of the mean. Statistical unpaired t-test was completed between 
negative pGEM dsRNA control and specific I. scapularis dsRNA for gene of 
interest. Three technical replicates for each treatment were performed within a 






Fig 15. LGTV negative strand genome replication levels following 
knockdown of I. scapularis transcripts for genes of interest in ISE6 cells. 
Abbreviated names for genes of interest and RNAi controls (pGEM and LGTV 
3UTR) include Fumar = fumarylacetoacetase (ISCW020196); ERP29 = 
endoplasmic reticulum protein 29 (ISCW018425); DPCD = 1-pyrroline-5-
carboxylate dehydrogenase (aldehyde dehydrogenase 4A1; ISCW015982); 
CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 = malate 
dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase 
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetyl-
CoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein 
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM 
plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of 
genome. Following transcript knockdown of genes of interest (60 hours post 
transfection with 10 ng dsRNA), effect on LGTV negative strand genome 
replication is identified. LGTV negative strand genome replication of dsRNA for 
genes of interest was compared to the negative control pGEM dsRNA (light gray 
bar). LGTV 3UTR dsRNA is the positive control (dark gray bar) directed towards 
the LGTV genome that was used for detrimental effect on LGTV genome 
replication. Relative transcript expression was used to identify fold change 
(transcript expression LGTV negative strand were compared to transcript 
expression of I. scapularis β-tubulin) of LGTV genome levels from ISE6 cells 
(~1x105 cells). Error bars represent standard error of the mean. Statistical unpaired 
t-test was completed between negative pGEM dsRNA control and specific I. 
scapularis dsRNA for gene of interest. Asterisks denote: *p value≤0.05, **p 
value≤0.01, and ***p value≤0.001. Three technical replicates for each treatment 
were performed within a biological replicate. Two biological replicates were 





Fig 16. Infectious LGTV replication after knockdown of I. scapularis 
transcripts for genes of interest in ISE6 cells. Abbreviated names for genes of 
interest and RNAi controls (pGEM and LGTV 3UTR) include Fumar = 
fumarylacetoacetase (ISCW020196); ERP29 = endoplasmic reticulum protein 29 
(ISCW018425); DPCD = 1-pyrroline-5-carboxylate dehydrogenase (aldehyde 
dehydrogenase 4A1; ISCW015982); CNHydro = pantetheine hydrolase (vanin; 
ISCW004822); MDH2 = malate dehydrogenase (ISCW003528); PARP = poly 
[ADP-ribose] polymerase (ISCW019519); CUKinase = UMP-CMP kinase 
(ISCW012446); ACAT1 = acetyl-CoA acetyltransferase (ISCW016117); Hypo195 
= hypothetical protein (ISCW011195); Hypo576 = hypothetical protein 
(ISCW020576); pGEM = pGEM plasmid cloning vector; LGTV 3UTR = LGTV strain 
TP21 3’ untranslated region of genome. Following transcript knockdown of genes 
of interest, effect on LGTV replication (infectious virus release) is identified. LGTV 
replication following transfections with dsRNA for genes of interest was compared 
to the negative control pGEM dsRNA (light gray bar). LGTV 3UTR dsRNA is the 
positive control (dark gray bar) directed towards the LGTV genome that was used 
for detrimental effect on LGTV replication. Plaque assays with BHK15 cells were 
utilized to identify effect on infectious LGTV release from ISE6 cells (~1x105 cells). 
Error bars represent standard error of the mean. Statistical unpaired t-test was 
completed between negative pGEM dsRNA control and specific I. scapularis 
dsRNA for gene of interest. Asterisks denote: **p value≤0.01 and ***p value≤0.001. 
Five technical replicates for each treatment were performed within a biological 





Fig 17. Infectious LGTV replication during knockdown of I. scapularis 
transcripts for genes of interest in ISE6 cells. Abbreviated names for genes of 
interest and RNAi controls (pGEM and LGTV 3UTR) include Fumar = 
fumarylacetoacetase (ISCW020196); ERP29 = endoplasmic reticulum protein 29 
(ISCW018425); DPCD = 1-pyrroline-5-carboxylate dehydrogenase (aldehyde 
dehydrogenase 4A1; ISCW015982); CNHydro = pantetheine hydrolase (vanin; 
ISCW004822); MDH2 = malate dehydrogenase (ISCW003528); PARP = poly 
[ADP-ribose] polymerase (ISCW019519); CUKinase = UMP-CMP kinase 
(ISCW012446); ACAT1 = acetyl-CoA acetyltransferase (ISCW016117); Hypo195 
= hypothetical protein (ISCW011195); Hypo576 = hypothetical protein 
(ISCW020576); pGEM = pGEM plasmid cloning vector; LGTV 3UTR = LGTV strain 
TP21 3’ untranslated region of genome. dsRNA transfection of genes of interest 
and LGTV infection were carried out at the same time. At 60 hours post 
transfection/infection, effect on LGTV replication (infectious virus release) was 
identified. LGTV replication during transfections with dsRNA for genes of interest 
was compared to the negative control pGEM dsRNA (light gray bar). LGTV 3UTR 
dsRNA is the positive control (dark gray bar) directed towards the LGTV genome 
that was used for detrimental effect on LGTV replication. Plaque assays with 
BHK15 cells were utilized to identify effect on infectious LGTV release from ISE6 
cells (~1x105 cells). Error bars represent standard error of the mean. Statistical 
unpaired t-test was completed between negative pGEM dsRNA control and 
specific I. scapularis dsRNA for gene of interest. Asterisks denote: *p value≤0.05, 
**p value≤0.01, and ***p value≤0.001. Five technical replicates for each treatment 
were performed within a biological replicate. One biological replicate shown; two 




Table 6. Summary of transcript knockdown effect of genes of interest on 































ISCW020196 Amino acid 
metabolism 













ISCW015982 Amino acid 
metabolism 





ISCW004822 Metabolism of 
cofactors & 
vitamins 













ISCW019519 Replication & 
repair 




























Unknown -- Decreased Decreased 
Δdenotes protein identified in I. scapularis synganglia [91] 
∞denotes Fumar, PARP, and CUKinase transcript knockdowns during LGTV 





Fig 18. Predicted cellular locations of selected proteins in ISE6 cells. Selected 
proteins are shown in cellular locations based off knowledge of orthologous protein 
locations. Black circles denote ribosomes. Blue lines denote positive strand, LGTV 
RNA genomes. Orange lines denote negative strand, LGTV RNA genomes used 
as a template for further positive strand, LGTV RNA genome production. Red 
circles denote viral proteins in association with replication complexes on/in the ER. 
Purple particles/virions denote immature LGTV before prM-furin cleavage. Green 
circles denote furin, which cleaves pr from prM, creating mature LGTV. Different 







Fig 19. Predicted effects of genes of interest transcript knockdown on LGTV 
life cycle steps. Different colored proteins denote different expression levels 
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L,  Inerowicz HD, Sirohi D, Perera R, Hill CA, and Kuhn RJ. 2015. New tick protein 
targets to control transmission of tick-borne flaviviruses. Keystone Symposia- The 
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Arthropod Vector: The Controller of Transmission. Sagebrush Inn & Suites, Taos, NM. 
(poster presentation) 
*Perera R, Chotiwan N, Vargus I, Andre B, Grabowski J, Hopf-jannasch A, Hedrick V, 
Gough E, Nakayasu E, Sirohi D, Hill CA, Kuhn RJ. 2015. Metabolic pathways that 
regulate vector competence in Aedes aegypti during dengue virus infection. Keystone 
Symposia- The Arthropod Vector: The Controller of Transmission. Sagebrush Inn & 
Suites, Taos, NM. (Perera oral presentation) 
*Grabowski J, Gulia-Nuss M, Sobreira T, Hedrick V, Nakayasu E, Roumani AM, Paul 
L,  Inerowicz HD, Sirohi D, Perera R, Hill CA, and Kuhn RJ. 2015. New tick protein 
targets to control transmission of tick-borne flaviviruses. Interdisciplinary Graduate 
Program Reception. Purdue University. (poster presentation) 
*Grabowski J, Gulia-Nuss M, Sobreira T, Hedrick V, Nakayasu E, Roumani AM, Paul 
L,  Inerowicz HD, Sirohi D, Perera R, Hill CA, and Kuhn RJ. 2015. New tick protein 
targets to control transmission of tick-borne flaviviruses. Health and Disease: Science, 
Culture and Policy Poster Session. Purdue University, West Lafayette, IN. (program-
published abstract-Poster Presentation) 
*Chotiwan N, Vargus I, Grabowski J, Hopf-jannasch A, Hedrick V, Gough E, Nakayasu 
E,     Sirohi D, Hill CA, Kuhn RJ, Perera R. 2014. Exploring the cellular metabolome as a 
gateway to target dengue virus replication in the mosquito vector. Annual American 
Society of Tropical Medicine and Hygiene Meeting. New Orleans Sheraton Hotel, New 
Orleans, LA. (program-published abstract-Chotiwan oral presentation) 
*Chotiwan N, Vargus I, Grabowski J, Hopf-jannasch A, Hedrick V, Gough E, Sirohi D, 
Hill CA, Kuhn RJ, Perera R. 2014. Analysis of the lipidome of the mosquito vector 
during dengue virus infection. Annual American Society for Virology Meeting. Colorado 
State University, Fort Collins, CO. (program-published abstract-Chotiwan poster 
presentation) 
*Grabowski J, Perera R, Roumani AM, Hedrick V, Inerowicz HD, Gulia-Nuss M, Nuss 
AB, Hill CA, and Kuhn RJ. 2014. Host proteome changes following infection with 
Langat virus: energy-associated and glutaminolysis enzymes involved in tick-borne 
flavivirus infection. Annual American Society for Virology Meeting. Colorado State 
University, Fort Collins, CO. (program-published abstract-Oral Presentation) 
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn, 
R. 2014. Host proteome changes following infection with the Langat virus: identification 
of novel targets for tick-borne flavivirus control. 2014 ACTS Translational Science 
Meeting. Omni Shoreham Hotel, Washington D.C. (program-published abstract-Poster) 
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn, 
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular 
proteomic screen: identification of novel targets for tick-borne flavivirus control. 2013 
Entomological Society of America Meeting. Austin Convention Center, Austin, TX. 
(program-published abstract-Poster) 
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn, 
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular 
proteomic screen: identification of novel targets for tick-borne flavivirus control. 2013 




*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn, 
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular 
proteomic screen: identification of novel targets for tick-borne flavivirus control. 7th 
Annual Arthropod Genomics Symposium. Notre Dame University. (program-published 
abstract-Poster) 
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn, 
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular 
proteomic screen: a novel system to discover host proteins for viral-therapeutic 
development. 2013 CTSA National Predoctoral Programs Meeting. Mayo Clinic. 
(program-published abstract-Poster) 
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn, 
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular 
proteomic screen: identification of novel targets for tick-borne flavivirus control. 
Interdisciplinary Graduate Program Reception. Purdue University. (poster presentation) 
*Perera, R, Hopf-Jannasch, A, Hedrick, V, Grabowski, J, Hill, C, and Kuhn, R. 2013. A 
balancing act: Changes in the cellular metabolome required for Dengue virus replication. 
Keystone Symposia: Positive Strand RNA Viruses. Boston, Massachusetts. (program-
published abstract: Perera oral presentation) 
*Perera, R, Hopf-Jannasch, A, Khadka, S, Grabowski, J, Edwards, T, LaCount, D, Hill, 
C, and Kuhn, R. 2013. Invading the cellular metabolome: A hallmark of Dengue virus 
infection of the human host and mosquito vector. 32nd Annual Meeting of American 
Society of Virology. Penn State University. (submitted abstract: Perera poster 
presentation) 
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn, 
R. 2012. Properties of tick-borne Langat virus during growth in Ixodes scapularis ISE6 
cells and host proteome change following infection. 2012 Annual Indiana CTSI Meeting. 
Indiana University-Purdue University Indianapolis University. (program-published 
abstract-Oral Presentation) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following 
infection. 31st Annual Meeting of American Society for Virology. University of 
Wisconsin-Madison. (program-published abstract-Oral Presentation) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following 
infection. Entomological Society of America: North Central Branch Meeting. University 
of Nebraska.  (program-published abstract-Oral Presentation) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following 
infection. Interdisciplinary Graduate Program Reception. Purdue University. (program-
published abstract-Poster) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following 
infection. 127th Annual Meeting of Indiana Academy of Science: Microbiology & 




*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following 
infection. Purdue Chapter Sigma Xi Poster Award Competition. Purdue University. 
(program-published abstract-Poster) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2011. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells and host proteomic change following 
infection. Biological Sciences Retreat. Purdue University. (program-published abstract-
Poster) 
*Perera, R, Riley, C, Junjohn, J, Edwards, T, Hopf-Jannasch, A, Mezengie, G, 
Grabowski, J, Hill, C, Metz, T, Moore, R, Weitz, K, Pasa-Tolic, L, Adamec, J, and 
Kuhn, R. 2011. Dengue virus alters membrane architecture and lipid composition of 
mammalian and insect cells during its replication cycle. 4th Annual Membrane 
Symposium on Center for Basic and Applied Studies on Membrane Proteins (PUBAMS). 
Purdue University. (program-published abstract: Perera oral presention) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2011. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells. Interdisciplinary Graduate Program 
Reception. Purdue University. (program-published abstract-Poster) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2011. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells. Entomological Society of America: 
North Central Branch Meeting. University of Minnesota. (program-published abstract-
Poster) 
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2010. Properties of tick-borne Langat 
virus during growth in Ixodes scapularis ISE6 cells. Purdue Chapter Sigma Xi Poster 
Award Competition. Purdue University. (program-published abstract-Poster) 
*Grabowski, J and Kreps, D. 2009. Monitoring Deer Ticks (Ixodes scapularis) and 
Borrelia burgdorferi in Southern Kosciusko County, IN. Manchester University Student 
Research Symposium, North Manchester, IN. (program-published abstract -Oral 
Presentation) 
*Grabowski, J and Kreps, D. 2008. Monitoring Deer Ticks (Ixodes scapularis) and 
Borrelia burgdorferi in Southern Kosciusko County, IN. Manchester University Science 
Seminar, North Manchester, IN. (program-published abstract -Oral Presentation) 
Video: http://users.manchester.edu/Facstaff/CWatson/Seminar/0809/Sept22/Sept22.htm 
*Grabowski, J, Killilea, M, and Ostfeld, R. 2007. Invasive earthworm species effect on 
the density and microscale habitat of Ixodes scapularis nymphs in Dutchess County, NY. 
123rd Annual Meeting of Indiana Academy of Science: Ecology Section. University of 
Indianapolis. (program-published abstract -Oral Presentation) 
*Grabowski, J, Killilea, M, and Ostfeld, R. 2007. Invasive earthworm species effect on 
the density and microscale habitat of Ixodes scapularis nymphs in Dutchess County, NY. 
Cary Institute for Ecosystems Study REU Undergraduate Symposium. Millbrook, NY. 
(program-published abstract -Oral Presentation) 
 
Research Advisor of Lab Personnel: 




*Purdue Department of Biological Sciences Undergraduate Student- Scott Marr       
2011-2012 
*Manchester Department of Biology Undergraduate Students- Kyle Carlson, Alec 




*Coalition for Clinical and Translational Science Capitol Hill Advocacy Day – Indiana 
Team Member, Washington D.C.          
     2014 
News Story Result: http://news.sciencemag.org/funding/2014/06/u-s-senate-bill-would-
give-nih-2-raise-2015 
*Bioinformatics Resource for Invertebrate Vectors of Human Pathogens (VectorBase) 
User Advisor 
Website: https://www.vectorbase.org/sug         
2014-current 
*Influenza Research Database (IRD)/Virus Pathogen Resource (ViPR) User Advisor 
Website:http://www.viprbrc.org/brc/staticContent.do?decorator=vipr&type=ViprInfo&su
btype=ScienceSupport            
2012-current  
*Teacher Assistant, ENTM 525: Medical and Veterinary Entomology       
spring 2013 
• Dr. Catherine A Hill, Purdue University, ENTM Department   
                 
*Personal Invitations 
• NIAID/NIH Rocky Mountain Laboratories, Laboratory of Virology Seminar 
o Host: Marshall E. Bloom 
o Seminar Title: The proteomics of tick-flavivirus interactions: studies of 
the Ixodes scapularis-Langat virus system                  March 2015 
• Office of Interdisciplinary Graduate Programs Most Outstanding Interdisciplinary 
Program Award (MOIPA) Reviewer           2014-2015 
• Student presentation at Society for Vector Ecology Meeting (kindly declined) 
    2014        
• PULSe 1st Year Poster Competition          2014 
o Judge 
• Purdue Entomology Department Booth Exhibitor        2013 
o Entomological Society of America Meeting 
• Office of Interdisciplinary Graduate Programs Student Resource Panel Member      
    2013 
o Discussion Panelist 
• PULSe Seminar Series Talk (October 15)         2012 
• PULSe “NSF Review Workshop”           2012-2013 
o Co-Host Speaker 




• Purdue Department of Entomology “Survival Skills Workshop”: Applying for 
NSF                 2011 
o Host Speaker 
• PULSe 1st Year Poster Competition          2011 
o Judge 
• NSF Peer Mentoring-Graduate Fellow Panel Member, Purdue Graduate School                
                  2010-2014                  
o Discussion Panelist 
o Provided successful application for public view 
o Liason for students regarding NSF GRFP questions 
*PGSG Senator              2012-2013 
• Advancement Committee 
*PULSe Graduate Student Organization (GSO) 
• Vice President                                  2011-2012 
• Activities Coordinator                                  2010-2011 
*Purdue SURF Symposium Poster Presentation Judge              2011 
*Poster Presentation Title: New tick protein targets to control transmission of tick-borne 
flaviviruses 
• Keystone Symposia- The Arthropod Vector: The Controller of Transmission. 
Sagebrush Inn & Suites, Taos, NM.          2015 
• Interdisciplinary Graduate Program Reception, Purdue University, IN.     2015 
• Health and Disease: Science, Culture and Policy Poster Session, Purdue 
University, IN.                           2015 
*Poster Presentation Title: Host proteome and energy/glutaminolysis enzyme change 
with Langat infection 
• Interdisciplinary Graduate Program Reception, Purdue University, IN.     2014 
• PULSe Welcome Reception and Poster Competition, Purdue University, IN. 2014 
*Oral Presentation Title: Host proteome and energy/glutaminolysis enzyme change with 
Langat infection 
• Annual ASV Meeting: Flavivirus I Section, Fort Collins, CO      2014 
• Rossmann/Kuhn Seminar, West Lafayette, IN        2014 
• ICTSI Spring Reception, West Lafayette, IN         2014 
*Oral Presentation Title: Tick-flavivirus analysis and host proteomic change following 
infection 
• Infectious Disease Research in Progress Seminar: Purdue University, IN     2013 
• ICTSI Presentation Day: Purdue University, IN        2013 
• PULSe Seminar Series Talk: Purdue University, IN        2012 
• Annual ASV Meeting: Flavivirus I Section, Madison, WI.                               2012 
• Entomological Society of America NCB Meeting, University of Nebraska, NE.    
    2012 
• Annual IAS Meeting: Microbio & Mol Bio Section, Purdue University, IN.   2012 
• Entomology Methods Seminar: Purdue University, IN                                     2012 
*Poster Presentation Title: LGTV-ISE6 proteomic screen-Langat virus growth in ISE6 
cells and host proteomic change
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• ACTS Translational Science Meeting: T0-Basic Scientific Discovery Section, 
Omni Shoreham Hotel, Washington D.C.              2014 
• Entomological Society of America: Austin Convention Center, Austin, TX    2013 
• Annual Indiana CTSI Meeting: IUPUI, Indianapolis, IN       2013 
• Arthropod Genomics Symposium, University of Notre Dame, IN      2013 
• CTSA National Predoctoral Programs Meeting, Mayo Clinic, Rochester, MN2013 
• Interdisciplinary Graduate Program Reception, Purdue University, IN.     2013 
• Annual Indiana CTSI Meeting: IUPUI, Indianapolis, IN       2012 
• Interdisciplinary Graduate Program Reception, Purdue University, IN.     2012 
• Purdue Chapter Sigma Xi Poster Award Competition, Purdue University, IN.2012 
• Biological Sciences Retreat, Swan Lake Resort, Plymouth, IN      2011 
*Poster Presentation Title: Langat virus growth in ISE6 cells 
• Interdisciplinary Graduate Program Reception, Purdue University, IN.     2011 
• Entomological Society of America NCB Meeting, University of Minnesota, MN.  
    2011 
• Purdue Chapter Sigma Xi Poster Award Competition, Purdue University, IN.2010 
*Purdue University Graduate School Exam Proctor           2009-2010 
*Oral Presentation Title: Lyme Disease Dynamics of Southern Kosciusko county, IN 
• Manchester College Student Research Symposium, N. Manchester, IN.     2009 
• Manchester College Science Seminar, N. Manchester, IN.         2008 
Video: 
http://users.manchester.edu/Facstaff/CWatson/Seminar/0809/Sept22/Sept22.htm 
*Oral Presentation Title: Invasive Earthworms and Nymphal Tick Interaction Dynamics 
• Annual IAS Conference: Ecology Section, Indianapolis, IN.                           2007 
• CIES REU Undergraduate Symposium, Millbrook, NY.        2007  
• Manchester College Science Seminar, N. Manchester, IN.         2007 
 
Community/Volunteer Activities: 
*Purdue Spring Fest, “Magic Milk,” Purdue University, IN.           2012 
Educate students and families on the nature of lipids in milk and how to conduct simple 
science. 
*Purdue zipTrips Speaker, “Disease Detectives” 7th grade episode.                    2009-2011 
+Association for Communication Excellence in Agriculture, Natural Resources, 
and Life and Human Sciences Silver Award for the 2011 ACE Critique and 
Awards Program in the category of Electronic Media, Video: Class 30 programs 
+International, world-wide viewed PBS-broadcasted program to encourage 
interest in STEM sciences  
+Recipient of Purdue 2012 College of Agriculture TEAM Award 
+2010 show: video.dis.purdue.edu/bns/Agriculture/zipTrips_101118.wmv 
*PULSe Science Night Speaker, “DNA Extraction,” Sunnyside Middle School, IN.  2011 
Educate elementary students and families on the nature of DNA and how to conduct 
simple science. 
*PULSe Science Night Speaker, “Fun with Microscopy,” Dayton Elementary School, IN.      
               2011
168 
Educate elementary students and parents on the science of microscopy and 
microorganisms. 
*Big Ten Graduate Expo, Purdue Graduate School.  2010 
Graduate student panel discussion for undergraduate students 
*“Sharing Science,” Cary Institute of Ecosystem Studies.       2007 
Science-based workshop for underprivileged New York City High school students. 
Professional Society Student Membership: 
*American Society for Virology (ASV)  2012-present 
*American Society of Tropical Medicine and Hygiene (ASTMH)   2011-present 
*Entomological Society of America   2011-present 
*American Association for the Advancement of Science (AAAS)   2011-present 
*Association for Clinical & Translational Science     2014 
*Indiana Academy of Sciences (IAS)     2012 
*Wildlife Disease Association     2011 
Workshops Attended: 
*VectorBase Workshop, University of Notre Dame, IN  2013 
*Virus Pathogen Resource (ViPR) workshop, Purdue University, IN  2011 
Resource link: http://www.viprbrc.org/brc/home.do?decorator=vipr
*Annotating a genome sequence: gene models workshop, Purdue University, IN  2011 
Resource link: http://academy.nescent.org/wiki/Next-gen_sequencing
Semester Lectures Attended: 
*CHEM 69600: Adv Proteomics, Metabolomics, and Bioinformatics, Purdue University,
IN  spring 2011-2012 
*BIOL 41600: Viruses and Viral Disease, Purdue University, IN
 spring 2011-2012 
      spring 2012-2013 
Animal Care and Use Training 
*Mouse and Rat Handling and Restraint       5/28/2013 
*Mouse and Rat Basic Injection Techniques (SC, IP, IM)       6/6/2013 
*Mouse and Rat Gas Anesthesia       6/25/2013 
*Mouse Euthanasia Techniques, Dissection, and Organ Identification  8/5 and 9/19/13 

169
170
171
172
173
174
175
176
177
178
